Code | Display | Comments |
---|
1-8 | Acyclovir [Susceptibility] | | |
10-9 | Amdinocillin [Susceptibility] by Serum bactericidal titer | | |
100-8 | Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC) | | |
1000-9 | DBG Ab [Presence] in Serum or Plasma from Blood product unit | | |
10000-8 | R wave duration in lead AVR | |
100002-5 | Specimen care is maintained | | |
100003-3 | Team communication is maintained throughout care | | |
100004-1 | Demonstrates knowledge of the expected psychosocial responses to the procedure | | |
100005-8 | Demonstrates knowledge of nutritional management related to the procedure | | |
100006-6 | Demonstrates knowledge of medication management | | |
100007-4 | Demonstrates knowledge of pain management | | |
100008-2 | Demonstrates knowledge of wound management | | |
100009-0 | Demonstrates knowledge of the procedure and expected results | | |
10001-6 | R wave duration in lead I | |
100010-8 | No injury related to procedure equipment, medical supplies, or instrumentation | | |
100011-6 | No injury related to an electrical source | | |
100012-4 | Participates in decisions affecting the patient's plan of care | | |
100013-2 | Participates in the discharge process | | |
100014-0 | Psychosocial health is maintained at or improved from baseline | | |
100015-7 | No injury related to positioning due to care or procedure | | |
100016-5 | No injury related to a laser source | | |
100017-3 | Perioperative nursing data set outcomes panel [PNDS] | | |
100018-1 | Hospice care Note | |
100019-9 | ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | | |
10002-4 | R wave duration in lead II | |
100020-7 | GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | | |
100021-5 | GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | | |
100022-3 | IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | | |
100023-1 | IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | | |
100024-9 | SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | | |
100025-6 | SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | | |
100026-4 | MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | | |
100027-2 | SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | | |
100028-0 | FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | | |
100029-8 | Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method | | |
10003-2 | R wave duration in lead III | |
100030-6 | Axis I: Temporal aspects score [Mainz Pain Staging System] | | |
100031-4 | Axis II: Spatial aspects score [Mainz Pain Staging System] | | |
100032-2 | Axis III: Drug taking behavior score [Mainz Pain Staging System] | | |
100033-0 | Axis IV: Utilization of the health care system score [Mainz Pain Staging System] | | |
100034-8 | Provider of automated external defibrillator use | |
100035-5 | Exam finding location of Chest | |
100036-3 | Exam finding location of Lung | |
100037-1 | Patient contact disposition EMS unit | |
100038-9 | Patient evaluation disposition EMS unit | |
100039-7 | Crew disposition for patient care EMS unit | |
10004-0 | R wave duration in lead V1 | |
100040-5 | Patient transport disposition EMS unit | |
100041-3 | Aminoglycoside [Susceptibility] | | |
100042-1 | Atovaquone [Susceptibility] | | |
100043-9 | Azithromycin+Ethambutol [Susceptibility] | | |
100044-7 | Cefcapene [Susceptibility] | | |
100045-4 | Cefozopran [Susceptibility] | | |
100046-2 | Cefquinome [Susceptibility] | | |
100047-0 | Cefteram [Susceptibility] | | |
100048-8 | Clarithromycin+Ethambutol [Susceptibility] | | |
100049-6 | Eravacycline [Susceptibility] | | |
10005-7 | R wave duration in lead V2 | |
100050-4 | Erythromycin+Ethambutol [Susceptibility] | | |
100051-2 | Ethambutol+rifAMPin [Susceptibility] | | |
100052-0 | Flomoxef [Susceptibility] | | |
100053-8 | Fluoroquinolone [Susceptibility] | | |
100054-6 | Gamithromycin [Susceptibility] | | |
100055-3 | Optochin [Susceptibility] | | |
100056-1 | Panipenem [Susceptibility] | | |
100057-9 | Prothionamide [Susceptibility] | | |
100058-7 | Prulifloxacin [Susceptibility] | | |
100059-5 | Rifapentine [Susceptibility] | | |
10006-5 | R wave duration in lead V3 | |
100060-3 | Tildipirosin [Susceptibility] | | |
100061-1 | Tosufloxacin [Susceptibility] | | |
100062-9 | Standard Dermatology Outcome Measures panel | |
100063-7 | Primary skin concern | |
100064-5 | Itch severity Reporting Period - Reported | |
100065-2 | Satisfied with treatment | |
100066-0 | Specular microscopy panel | |
100067-8 | Eye Image magnification | |
100068-6 | Right eye Fixation point [Angle] | |
100069-4 | Left eye Fixation point [Angle] | |
10007-3 | R wave duration in lead V4 | |
100070-2 | Right cornea Cell density | |
100071-0 | Left cornea Cell density | |
100072-8 | Right cornea Coefficient of variation | |
100073-6 | Left cornea Coefficient of variation | |
100074-4 | Right cornea Hexagonality | |
100075-1 | Left cornea Hexagonality | |
100076-9 | Right cornea Endothelial cells counted | |
100077-7 | Left cornea Endothelial cells counted | |
100078-5 | Right cornea Endothelial cell area.min | |
100079-3 | Left cornea Endothelial cell area.min | |
10008-1 | R wave duration in lead V5 | |
100080-1 | Right cornea Endothelial cell area.max | |
100081-9 | Left cornea Endothelial cell area.max | |
100082-7 | Right cornea Endothelial cell area.mean | |
100083-5 | Left cornea Endothelial cell area.mean | |
100084-3 | Right cornea Cell area.standard deviation | |
100085-0 | Left cornea Cell area.standard deviation | |
100086-8 | Right cornea Type of Analysis method by Specular microscopy | |
100087-6 | Toxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot | | |
100088-4 | Taenia solium larva Ab bands panel - Serum by Immunoblot | | |
100089-2 | Taenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot | | |
10009-9 | R wave duration in lead V6 | |
100090-0 | Taenia solium larva 45kD Ab [Presence] in Serum by Immunoblot | | |
100091-8 | Trypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay | | |
100092-6 | Trypanosoma cruzi Ab bands panel - Serum by Immunoblot | | |
100093-4 | Trypanosoma cruzi 15-16kD IgG Ab [Presence] in Serum by Immunoblot | | |
100094-2 | Trypanosoma cruzi 21-22kD IgG Ab [Presence] in Serum by Immunoblot | | |
100095-9 | Trypanosoma cruzi 27-28kD IgG Ab [Presence] in Serum by Immunoblot | | |
100096-7 | Trypanosoma cruzi 42kD IgG Ab [Presence] in Serum by Immunoblot | | |
100097-5 | Trypanosoma cruzi 45-47kD IgG Ab [Presence] in Serum by Immunoblot | | |
100098-3 | Trypanosoma cruzi 120-200kD IgG Ab [Presence] in Serum by Immunoblot | | |
100099-1 | Trypanosoma cruzi 160kD IgG Ab [Presence] in Serum by Immunoblot | | |
1001-7 | DBG Ab [Presence] in Serum or Plasma from Donor | | |
10010-7 | R' wave amplitude in lead AVF | |
100100-7 | Fasciola sp IgG Ab [Presence] in Serum by Immunoassay | | |
100101-5 | Fasciola sp 8-9kD IgG Ab [Presence] in Serum by Immunoblot | | |
100102-3 | Fasciola sp 27-28kD IgG Ab [Presence] in Serum by Immunoblot | | |
100103-1 | Fasciola sp 60kD IgG Ab [Presence] in Serum by Immunoblot | | |
100104-9 | Fasciola sp 42kD IgG Ab [Presence] in Serum by Immunoblot | | |
100105-6 | Filaria IgG and IgM panel - Serum | | |
100106-4 | Filaria IgG Ab [Presence] in Serum by Immunoassay | | |
100107-2 | Leishmania sp IgG Ab [Presence] in Serum by Immunoassay | | |
100108-0 | Leishmania sp IgG Ab [Units/volume] in Serum by Immunoassay | | |
100109-8 | Leishmania sp Ab bands panel - Serum by Immunoblot | | |
10011-5 | R' wave amplitude in lead AVL | |
100110-6 | Leishmania sp 14kD IgG Ab [Presence] in Serum by Immunoblot | | |
100111-4 | Leishmania sp 16kD IgG Ab [Presence] in Serum by Immunoblot | | |
100112-2 | Fasciola sp Ab bands panel - Serum by Immunoblot | | |
100113-0 | Helicobacter pylori Ab panel - Serum | | |
100114-8 | Toxoplasma gondii 30kD Ab [Presence] in Serum by Immunoblot | | |
100115-5 | Toxoplasma gondii 31kD Ab [Presence] in Serum by Immunoblot | | |
100116-3 | Toxoplasma gondii 33kD Ab [Presence] in Serum by Immunoblot | | |
100117-1 | Toxoplasma gondii 40kD Ab [Presence] in Serum by Immunoblot | | |
100118-9 | Toxoplasma gondii 41kD Ab [Presence] in Serum by Immunoblot | | |
100119-7 | Toxoplasma gondii 45kD Ab [Presence] in Serum by Immunoblot | | |
10012-3 | R' wave amplitude in lead AVR | |
100120-5 | Chlamydia trachomatis Ab panel - Serum | | |
100121-3 | Chlamydia trachomatis IgA Ab [Presence] in Serum by Immunoassay | | |
100122-1 | Chlamydophila pneumoniae Ab panel - Serum | | |
100123-9 | Chlamydophila pneumoniae IgA Ab [Presence] in Serum by Immunoassay | | |
100124-7 | Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum by Immunoassay | | |
100125-4 | Chlamydophila psittaci Ab panel - Serum | | |
100126-2 | Bordetella pertussis Ab.IgG panel - Serum | | |
100127-0 | Campylobacter sp Ab panel - Serum | | |
100128-8 | Cryptococcus sp Ag panel - Serum | | |
100129-6 | Schistosoma sp Ab [Titer] in Serum by Hemagglutination | | |
10013-1 | R' wave amplitude in lead I | |
100130-4 | Schistosoma mansoni Ab [Presence] in Serum by Immunoblot | | |
100131-2 | Schistosoma sp 8kD Ab [Presence] in Serum by Immunoblot | | |
100132-0 | Schistosoma sp 9kD Ab [Presence] in Serum by Immunoblot | | |
100133-8 | Schistosoma sp 10kD Ab [Presence] in Serum by Immunoblot | | |
100134-6 | Schistosoma sp 11kD Ab [Presence] in Serum by Immunoblot | | |
100135-3 | Schistosoma sp 12-13kD Ab [Presence] in Serum by Immunoblot | | |
100136-1 | Schistosoma sp 14-15kD Ab [Presence] in Serum by Immunoblot | | |
100137-9 | Schistosoma sp 15-16kD Ab [Presence] in Serum by Immunoblot | | |
100138-7 | Schistosoma sp 18-19kD Ab [Presence] in Serum by Immunoblot | | |
100139-5 | Schistosoma sp 22-24kD Ab [Presence] in Serum by Immunoblot | | |
10014-9 | R' wave amplitude in lead II | |
100140-3 | Schistosoma sp 30-34kD Ab [Presence] in Serum by Immunoblot | | |
100141-1 | Schistosoma sp 65kD Ab [Presence] in Serum by Immunoblot | | |
100142-9 | Schistosoma sp 70kD Ab [Presence] in Serum by Immunoblot | | |
100143-7 | Schistosoma sp 80kD Ab [Presence] in Serum by Immunoblot | | |
100144-5 | Schistosoma sp 95kD Ab [Presence] in Serum by Immunoblot | | |
100145-2 | Schistosoma sp 110kD Ab [Presence] in Serum by Immunoblot | | |
100146-0 | Schistosoma sp 120kD Ab [Presence] in Serum by Immunoblot | | |
100147-8 | Toxoplasma gondii Ab bands panel - Serum by Immunoblot | | |
100148-6 | Schistosoma sp Ab bands panel - Serum by Immunoblot | | |
100149-4 | 6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel - Urine and Serum or Plasma | | |
10015-6 | R' wave amplitude in lead III | |
100150-2 | 6(R+S)-oxo-propylpiperidine-2-carboxylate [Moles/volume] in Plasma | | |
100151-0 | 6-oxo-piperidine-2-carboxylate [Moles/volume] in Plasma | | |
100152-8 | 6-oxo-piperidine-2-carboxylate/Creatinine [Molar ratio] in Urine | | |
100153-6 | 6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine [Molar ratio] in Urine | | |
100154-4 | Specimen collection supervision level | | |
100155-1 | Left cornea Type of Analysis method by Specular microscopy | |
100156-9 | SARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection | | |
100157-7 | SARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing | | |
100158-5 | Microalbumin [Mass/volume] in Urine collected for unspecified duration | | |
100159-3 | Knee Society Score pre-op panel [Knee Society Score] | | |
10016-4 | R' wave amplitude in lead V1 | |
100160-1 | Knee replacement | |
100161-9 | Charnley Functional Classification | |
100162-7 | Knee alignment W standing X-ray measured | |
100163-5 | Knee medial AndOr lateral instability W full extension | |
100164-3 | Knee AP instability W 90 degree flexion | |
100165-0 | Knee range of motion | |
100166-8 | Flexion contracture range of Knee | |
100167-6 | Extensor lag range of Knee | |
100168-4 | Knee pain severity with level walking | | |
100169-2 | Knee pain severity with stairs or inclines | | |
10017-2 | R' wave amplitude in lead V2 | |
100170-0 | Knee feels normal | | |
100171-8 | Satisfaction with level of knee pain while sitting | | |
100172-6 | Satisfaction with level of knee pain while lying in bed | | |
100173-4 | Satisfaction with knee function while getting out of bed | | |
100174-2 | Satisfaction with knee function while performing light household duties | | |
100175-9 | Satisfaction with knee function while performing recreational activities | | |
100176-7 | Expect surgery to relieve pain | | |
100177-5 | Expect surgery will improve ability to perform activities of daily living | | |
100178-3 | Expect surgery will improve ability to perform leisure, recreational, or sports activities | | |
100179-1 | Walk without assistive mobility devices | | |
10018-0 | R' wave amplitude in lead V3 | |
100180-9 | Assistive mobility devices used | | |
100181-7 | Assistive mobility devices used due to health condition | | |
100182-5 | Duration of standing before sitting due to knee discomfort | | |
100183-3 | Duration of walking before stopping due to knee discomfort | | |
100184-1 | How bothersome is knee when walking on an uneven surface | | |
100185-8 | How bothersome is knee when turning or pivoting leg | | |
100186-6 | How bothersome is knee when climbing up or down a flight of stairs | | |
100187-4 | How bothersome is knee when getting up from a low seat without armrests | | |
100188-2 | How bothersome is knee when getting into or out of a car | | |
100189-0 | How bothersome is knee when moving laterally | | |
10019-8 | R' wave amplitude in lead V4 | |
100190-8 | How bothersome is knee when climbing a ladder or step stool | | |
100191-6 | How bothersome is knee when carrying a bag for one block | | |
100192-4 | How bothersome is knee when squatting | | |
100193-2 | How bothersome is knee when kneeling | | |
100194-0 | How bothersome is knee when running | | |
100195-7 | Pain severity--during activity | | |
100196-5 | Pre-op total score [Knee Society Score] | | |
100197-3 | Exercise activity and pain severity panel | | |
100198-1 | Pre-op objective knee indicators score [Knee Society Score] | | |
100199-9 | Pre-op symptoms score [Knee Society Score] | | |
1002-5 | DBG Ab [Presence] in Serum or Plasma | | |
10020-6 | R' wave amplitude in lead V5 | |
100200-5 | Pre-op patient expectations score [Knee Society Score] | | |
100201-3 | Pre-op functional activities score [Knee Society Score] | | |
100202-1 | Pre-op discretionary knee activities score [Knee Society Score] | | |
100203-9 | Knee Society Score post-op panel [Knee Society Score] | | |
100204-7 | Accuracy of pre-surgery expectations of pain relief | | |
100205-4 | Accuracy of pre-surgery expectations to perform activities of daily living | | |
100206-2 | Accuracy of pre-surgery expectations to perform leisure, recreational, or sports activities | | |
100207-0 | Post-op total score [Knee Society Score] | | |
100208-8 | Post-op objective knee indicators score [Knee Society Score] | | |
100209-6 | Post-op symptoms score [Knee Society Score] | | |
10021-4 | R' wave amplitude in lead V6 | |
100210-4 | Post-op patient expectations score [Knee Society Score] | | |
100211-2 | Post-op functional activities score [Knee Society Score] | | |
100212-0 | Post-op discretionary knee activities score [Knee Society Score] | | |
100213-8 | Prostate cancer multigene analysis in Blood or Tissue by Molecular genetics method | | |
100214-6 | Dental model prior authorization Document | |
100215-3 | Episode of care medical records Document Transplant surgery | |
100216-1 | Surgical synoptic report | |
100217-9 | Surgical oncology synoptic report | |
100218-7 | Surgical oncology of colon synoptic report | |
100219-5 | Surgical oncology of melanoma synoptic report | |
10022-2 | R' wave duration in lead AVF | |
100220-3 | Surgical oncology of breast synoptic report | |
100221-1 | Surgical oncology of thyroid synoptic report | |
100222-9 | Surgical oncology of pancreas synoptic report | |
100223-7 | Physical findings of Retina Narrative | |
100224-5 | Cardiac left ventricular segmental wall motion by echo panel | |
100225-2 | Bone density quantitative ultrasound study | |
100226-0 | Small bowel capsule endoscopy study Document | |
100227-8 | Colon capsule endoscopy study Document | |
100228-6 | Upper gastrointestinal capsule endoscopy study Document | |
100229-4 | Endoscopic ultrasound study Document | |
10023-0 | R' wave duration in lead AVL | |
100230-2 | Routine prenatal assessment panel | |
100231-0 | Endobronchial ultrasound study | |
100232-8 | Impacts of Events Scale-Revised panel | | |
100233-6 | Reminders brought back feelings about adverse event | | |
100234-4 | Trouble staying asleep | | |
100235-1 | Other things triggered persistent thoughts about adverse event | | |
100236-9 | Felt irritable AndOr angry | | |
100237-7 | Avoided getting upset when unintentionally thought about adverse event | | |
100238-5 | Thought about adverse event unintentionally | | |
100239-3 | Felt as if adverse event did not happen | | |
10024-8 | R' wave duration in lead AVR | |
100240-1 | Avoided reminders of adverse event | | |
100241-9 | Experienced mental images of adverse event | | |
100242-7 | Easily startled | | |
100243-5 | Tried to not think of adverse event | | |
100244-3 | Aware of feelings about adverse event, but did not address them | | |
100245-0 | Feelings about adverse event were numb | | |
100246-8 | Acted or felt the same as during adverse event | | |
100247-6 | Trouble falling asleep | | |
100248-4 | Waves of strong feelings about adverse event | | |
100249-2 | Tried to remove adverse event from memory | | |
10025-5 | R' wave duration in lead I | |
100250-0 | Trouble concentrating | | |
100251-8 | Reminders of adverse event caused physical reactions | | |
100252-6 | Had dreams about adverse event | | |
100253-4 | Felt watchful and on-guard | | |
100254-2 | Tried not to talk about adverse event | | |
100255-9 | Total score [Impact of Event Scale-Revised] | | |
100256-7 | Fallen in last 6 months | |
100257-5 | Feel unsteady when standing or walking | |
100258-3 | History of fall related injury | |
100259-1 | Aware of tactile sensations | | |
10026-3 | R' wave duration in lead II | |
100260-9 | Easy to describe thoughts AndOr feelings | | |
100261-7 | Critical of own thoughts AndOr feelings | | |
100262-5 | Able to notice distressing thoughts AndOr feelings without having to react | | |
100263-3 | Easily distracted | | |
100264-1 | Able to notice thoughts AndOr feelings without being overwhelmed | | |
100265-8 | Aware of dietary intake impact on self | | |
100266-6 | Difficult to describe thoughts AndOr feelings | | |
100267-4 | Aware of auditory stimuli | | |
100268-2 | Able to avoid immediate reaction in difficult situations | | |
100269-0 | Do things without paying attention | | |
10027-1 | R' wave duration in lead III | |
100270-8 | Recover quickly from distressing thoughts AndOr images | | |
100271-6 | Aware of olfactory stimuli | | |
100272-4 | Aware of visual stimuli | | |
100273-2 | Aware of emotions affect on thoughts AndOr behavior | | |
100274-0 | Observing score [FFMQ] | | |
100275-7 | Describing score [FFMQ] | | |
100276-5 | Acting with awareness score [FFMQ] | | |
100277-3 | Nonjudging score [FFMQ] | | |
100278-1 | Nonreactivity score [FFMQ] | | |
100279-9 | Total score [FFMQ] | | |
10028-9 | R' wave duration in lead V1 | |
100280-7 | Five Facet Mindfulness Questionnaire panel [FFMQ] | | |
100281-5 | D Ab [Units/volume] in Serum or Plasma | | |
100282-3 | Vaccine exemption certificate | |
100283-1 | Harris Hip Score panel [Harris Hip Score] | | |
100284-9 | Walking - functional ability | | |
100285-6 | Comfortable seated position | | |
100286-4 | Able to board public transportation | | |
100287-2 | Put on shoes and socks | | |
100288-0 | Absence of deformity score [Harris Hip Score] | | |
100289-8 | Absence of hip deformity measurements | | |
10029-7 | R' wave duration in lead V2 | |
100290-6 | Range of motion score [Harris Hip Score] | | |
100291-4 | Total score [Harris Hip Score] | | |
100292-2 | Pre-op patient satisfaction score [Knee Society Score] | | |
100293-0 | Hip Flexion range of motion | | |
100294-8 | Hip Abduction range of motion | | |
100295-5 | Hip Adduction range of motion | | |
100296-3 | Hip External rotation range of motion | | |
100297-1 | Hip Internal rotation range of motion | | |
100298-9 | Repetition count | |
100299-7 | Post-op patient satisfaction score [Knee Society Score] | | |
1003-3 | Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma | | |
10030-5 | R' wave duration in lead V3 | |
100300-3 | End time Unspecified body region | |
100301-1 | Start time Unspecified body region | |
100302-9 | Time period start and end panel Unspecified body region | |
100303-7 | Condition certainty of presence | |
100304-5 | Flights climbed [#] Reporting Period | |
100305-2 | IDH1 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method | | |
100306-0 | IDH2 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method | | |
100307-8 | Behavioral screening elder mistreatment | | |
100308-6 | Need help getting to essential places | | |
100309-4 | Activity support person | | |
10031-3 | R' wave duration in lead V4 | |
100310-2 | Reliability of support person | | |
100311-0 | Need help to make sure there is enough food, medicines or any other things needed in house | | |
100312-8 | Person or persons that makes sure there is enough food, medicines or any other things needed in house | | |
100313-6 | Need help with household things such as cook meals, help feed, or provide correct medicines each day | | |
100314-4 | Need help with house cleaning or yard work | | |
100315-1 | Need help getting out of bed, showered, or dressed | | |
100316-9 | Need help to make sure bills get paid | | |
100317-7 | Relationship of usual support person for daily activities | | |
100318-5 | Have help with finances AndOr financial decisions | | |
100319-3 | Relationship of financial support person | | |
10032-1 | R' wave duration in lead V5 | |
100320-1 | Financial support person usually asks for permission before making decisions | | |
100321-9 | Financial support person usually makes good decisions about finances | | |
100322-7 | Have access to paperwork for financial decisions made | | |
100323-5 | Financial support person forged signature | | |
100324-3 | Coercion of financial support person for signing a document in order to get money or possessions | | |
100325-0 | Experienced theft by support person | | |
100326-8 | Money spent or property sold without permission | | |
100327-6 | Stranger forged signature for financial gain | | |
100328-4 | Stranger forced document signature for financial gain | | |
100329-2 | Feared for safety due to verbal attack | | |
10033-9 | R' wave duration in lead V6 | |
100330-0 | Felt humiliated due to ridicule | | |
100331-8 | Coerced to do something | | |
100332-6 | Ignored by close friend or relative for extended period | | |
100333-4 | Physically hit or threatened | | |
100334-2 | Been physically hurt with some degree of injury | | |
100335-9 | Coerced sexual activity | | |
100336-7 | Coerced touching of private body parts of self or others | | |
100337-5 | Coerced to undress or expose private body area | | |
100338-3 | Photographed in any degree of nudity without consent | | |
100339-1 | Experienced attempted physical restraint | | |
10034-7 | S wave amplitude in lead AVF | |
100340-9 | Range of motion panel Hip | | |
100341-7 | Rubella virus IgG Ab index [Units/volume] in Serum and CSF | | |
100342-5 | Volatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry | | |
100343-3 | Influenza virus B RNA [Presence] in Saliva (oral fluid) by NAA with probe detection | | |
100344-1 | Influenza virus A RNA [Presence] in Saliva (oral fluid) by NAA with probe detection | | |
100345-8 | Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection | | |
100346-6 | Clotting time.extrinsic coagulation system activated.platelets inhibited of Blood by Rotational TEG | | |
100347-4 | Clot formation.extrinsic coagulation system activated.platelets inhibited [Time] in Blood by Rotational TEG | | |
100348-2 | Model for end-stage liver disease sodium score | |
100349-0 | US.doppler Penis vessels W vasodilator IV | |
10035-4 | S wave amplitude in lead AVL | |
100350-8 | Sesamum indicum 1 IgE Ab [Units/volume] in Serum | | |
100351-6 | Pioglitazone [Presence] in Serum or Plasma | | |
100352-4 | Rosiglitazone [Presence] in Serum or Plasma | | |
100353-2 | Norwalk Community Health Center Screening Tool [NCHC] | | |
100354-0 | Frequency of participating in multi-modal communication without assistance | | |
100355-7 | Frequency of participating in spoken language expression communication without assistance | | |
100356-5 | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA [Identifier] in Specimen by NAA with probe detection | | |
100357-3 | Naloxone [Presence] in Cord tissue by Screen method | | |
100358-1 | Phentermine [Presence] in Cord tissue by Screen method | | |
100359-9 | Gliadin 33 mer peptide [Mass/volume] in Stool by Immunoassay | | |
10036-2 | S wave amplitude in lead AVR | |
100360-7 | Brief Resilience Scale panel [BRS] | | |
100361-5 | Quickly recover from bad events | | |
100362-3 | Difficulty making it through stressful events | | |
100363-1 | Easily recover from a stressful event | | |
100364-9 | Difficulty recovering from bad events | | |
100365-6 | Easily recover from difficulties | | |
100366-4 | Lengthy recovery from setbacks | | |
100367-2 | Total Score BRS | | |
100368-0 | Amino Acids Urea Cycle Panel - Serum or Plasma by LC/MS/MS | | |
100369-8 | NM Thyroid gland Views W Tl-201 IV | |
10037-0 | S wave amplitude in lead I | |
100370-6 | Orthopoxvirus DNA [Identifier] in Specimen by NAA with probe detection | | |
100371-4 | Titin Ab [Units/volume] in Serum by Immunoassay | | |
100372-2 | Abiraterone [Mass/volume] in Serum or Plasma | | |
100373-0 | Eucheuma IgG Ab [Units/volume] in Serum | | |
100374-8 | Aloe vera IgG Ab [Units/volume] in Serum | | |
100375-5 | Anise IgG Ab [Units/volume] in Serum | | |
100376-3 | Bambusa vulgaris IgG Ab [Units/volume] in Serum | | |
100377-1 | Goat cheese IgG Ab [Units/volume] in Serum | | |
100378-9 | Sheep cheese IgG Ab [Units/volume] in Serum | | |
100379-7 | Leeks IgG Ab [Units/volume] in Serum | | |
10038-8 | S wave amplitude in lead II | |
100380-5 | Red cabbage IgG Ab [Units/volume] in Serum | | |
100381-3 | Mentha balsamea Wild IgG Ab [Units/volume] in Serum | | |
100382-1 | FDA package insert REMS addressed risk | |
100383-9 | Monkeypox virus DNA [Presence] in Specimen by NAA with probe detection | | |
100384-7 | Rapeseed IgG Ab [Units/volume] in Serum | | |
100385-4 | Corn salad IgG Ab [Units/volume] in Serum | | |
100386-2 | Rosemary IgG Ab [Units/volume] in Serum | | |
100387-0 | Poppy Seed IgG Ab [Units/volume] in Serum | | |
100388-8 | Cocoa IgG Ab [Units/volume] in Serum | | |
100389-6 | Pistachio IgG Ab [Units/volume] in Serum | | |
10039-6 | S wave amplitude in lead III | |
100390-4 | Sunflower Seed IgG Ab [Units/volume] in Serum | | |
100391-2 | Dates IgG Ab [Units/volume] in Serum | | |
100392-0 | Duck meat IgG Ab [Units/volume] in Serum | | |
100393-8 | Allergen Mushroom mix 2 (Xerocomus, Boletus) IgG Ab [Units/volume] in Serum | | |
100394-6 | Astacoidea IgG Ab [Units/volume] in Serum | | |
100395-3 | Carob IgG Ab [Units/volume] in Serum | | |
100396-1 | Brassica napus IgG Ab [Units/volume] in Serum | | |
100397-9 | Goat Meat IgG Ab [Units/volume] in Serum | | |
100398-7 | Goose meat IgG Ab [Units/volume] in Serum | | |
100399-5 | Ostrich meat IgG Ab [Units/volume] in Serum | | |
1004-1 | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells | | |
10040-4 | S wave amplitude in lead V1 | |
100400-1 | Quail meat IgG Ab [Units/volume] in Serum | | |
100401-9 | Rabbit meat IgG Ab [Units/volume] in Serum | | |
100402-7 | Venison meat IgG Ab [Units/volume] in Serum | | |
100403-5 | Guineafowl IgG Ab [Units/volume] in Serum | | |
100404-3 | Horse meat IgG Ab [Units/volume] in Serum | | |
100405-0 | Kefir IgG Ab [Units/volume] in Serum | | |
100406-8 | Butter IgG Ab [Units/volume] in Serum | | |
100407-6 | Camembert cheese IgG Ab [Units/volume] in Serum | | |
100408-4 | Emmental cheese IgG Ab [Units/volume] in Serum | | |
100409-2 | Processed cheese IgG Ab [Units/volume] in Serum | | |
10041-2 | S wave amplitude in lead V2 | |
100410-0 | Curd cheese IgG Ab [Units/volume] in Serum | | |
100411-8 | Sugar Beet IgG Ab [Units/volume] in Serum | | |
100412-6 | Chinese cabbage IgG Ab [Units/volume] in Serum | | |
100413-4 | Fennel Fresh IgG Ab [Units/volume] in Serum | | |
100414-2 | Gourd IgG Ab [Units/volume] in Serum | | |
100415-9 | Kale IgG Ab [Units/volume] in Serum | | |
100416-7 | Savoy cabbage IgG Ab [Units/volume] in Serum | | |
100417-5 | Vitis sp leaf IgG Ab [Units/volume] in Serum | | |
100418-3 | Liquorice IgG Ab [Units/volume] in Serum | | |
100419-1 | Snow pea IgG Ab [Units/volume] in Serum | | |
10042-0 | S wave amplitude in lead V3 | |
100420-9 | Fava bean IgG Ab [Units/volume] in Serum | | |
100421-7 | Chick Pea IgG Ab [Units/volume] in Serum | | |
100422-5 | Chicory IgG Ab [Units/volume] in Serum | | |
100423-3 | Allergy Mushroom Mix 1 (Button + oyster + Shiitaki + chanterelle mushroom) IgG Ab [Units/volume] in Serum | | |
100424-1 | 8(9)-Cholestenol [Mass/volume] in Serum or Plasma | | |
100425-8 | DiHydro T-Mas [Mass/volume] in Serum or Plasma | | |
100426-6 | Squalene [Mass/volume] in Serum or Plasma | | |
100427-4 | Stigmasterol [Mass/volume] in Serum or Plasma | | |
100428-2 | Carnitine free and total and acylcarnitine panel - Urine | | |
100429-0 | LRBA deficiency panel - Blood | | |
10043-8 | S wave amplitude in lead V4 | |
100430-8 | Cells.LRBA+/100 Cells.CD3+CD14-CD45+ in Blood by Flow cytometry (FC) | | |
100431-6 | Cells.CD3+CD14-CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) | | |
100432-4 | Cells.LRBA+/100 Cells.CD3-CD14-CD19+CD45+ in Blood by Flow cytometry (FC) | | |
100433-2 | Cells.CD3-CD14-CD19+CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) | | |
100434-0 | Orthopoxvirus.non-variola DNA [Presence] in Specimen by NAA with probe detection | | |
100435-7 | Glial fibrillary acidic protein [Mass/volume] in Serum by Immunoassay | | |
100436-5 | Ubiquitin carboxyl-terminal hydrolase-L1 [Mass/volume] in Serum by Immunoassay | | |
100437-3 | Norsufentanil [Mass/volume] in Urine by Confirmatory method | | |
100438-1 | Adolescent medicine Outpatient Progress note | |
100439-9 | Allergy and Immunology Outpatient Progress note | |
10044-6 | S wave amplitude in lead V5 | |
100440-7 | Allergy Outpatient Progress note | |
100441-5 | Attending Outpatient Progress note | |
100442-3 | Audiology Outpatient Progress note | |
100443-1 | Bariatric surgery Outpatient Progress note | |
100444-9 | Blood banking and transfusion medicine Outpatient Progress note | |
100445-6 | Bone Marrow Transplant Outpatient Progress note | |
100446-4 | Breastfeeding Outpatient Progress note | |
100447-2 | Burn management Outpatient Progress note | |
100448-0 | Cardiac surgery Outpatient Progress note | |
100449-8 | Cardiopulmonary Outpatient Progress note | |
10045-3 | S wave amplitude in lead V6 | |
100450-6 | Child and adolescent psychiatry Outpatient Progress note | |
100451-4 | Chiropractic medicine Outpatient Progress note | |
100452-2 | Clinical cardiac electrophysiology Outpatient Progress note | |
100453-0 | Clinical genetics Outpatient Progress note | |
100454-8 | Clinical neurophysiology Outpatient Progress note | |
100455-5 | Clinical pathology Outpatient Progress note | |
100456-3 | Colon and rectal surgery Outpatient Progress note | |
100457-1 | Consultant Outpatient Progress note | |
100458-9 | Outpatient COVID-19 Intubation Progress note | |
100459-7 | Outpatient COVID-19 Progress note | |
10046-1 | S wave duration in lead AVF | |
100460-5 | Dermatology Outpatient Progress note | |
100461-3 | Developmental-behavioral pediatrics Outpatient Progress note | |
100462-1 | Dialysis and Therapeutic apheresis Outpatient Progress note | |
100463-9 | Eating disorders Outpatient Progress note | |
100464-7 | Endocrinology Outpatient Progress note | |
100465-4 | Family medicine Outpatient Progress note | |
100466-2 | Gastroenterology Outpatient Progress note | |
100467-0 | Geriatric medicine Outpatient Progress note | |
100468-8 | Gynecologic oncology Outpatient Progress note | |
100469-6 | Gynecology Outpatient Progress note | |
10047-9 | S wave duration in lead AVL | |
100470-4 | Healthcare navigator Outpatient Progress note | |
100471-2 | Heart failure Outpatient Progress note | |
100472-0 | Heart failure+Transplant cardiology Outpatient Progress note | |
100473-8 | Hematology Outpatient Progress note | |
100474-6 | Hematology+Medical oncology Outpatient Progress note | |
100475-3 | Hepatology Outpatient Progress note | |
100476-1 | Immunology Outpatient Progress note | |
100477-9 | Infectious disease Outpatient Progress note | |
100478-7 | Internal medicine Outpatient Progress note | |
100479-5 | Interventional cardiology Outpatient Progress note | |
10048-7 | S wave duration in lead AVR | |
100480-3 | Interventional radiology Outpatient Progress note | |
100481-1 | Outpatient Mechanical circulatory support Progress note | |
100482-9 | Medical Aid in Dying Outpatient Progress note | |
100483-7 | Mental health Outpatient Progress note | |
100484-5 | Multi-specialty program Outpatient Progress note | |
100485-2 | Neonatal perinatal medicine Outpatient Progress note | |
100486-0 | Nephrology Outpatient Progress note | |
100487-8 | Neurological surgery Outpatient Progress note | |
100488-6 | Neurology Outpatient Progress note | |
100489-4 | Neurology with special qualifications in child neurology Outpatient Progress note | |
10049-5 | S wave duration in lead I | |
100490-2 | Nurse practitioner Outpatient Progress note | |
100491-0 | Nurse Outpatient Progress note | |
100492-8 | Nutrition and dietetics Outpatient Progress note | |
100493-6 | Obstetrics and Gynecology Outpatient Progress note | |
100494-4 | Obstetrics Outpatient Progress note | |
100495-1 | Occupational therapy Outpatient Progress note | |
100496-9 | Oncology Outpatient Progress note | |
100497-7 | Ophthalmology Outpatient Progress note | |
100498-5 | Optometry Outpatient Progress note | |
100499-3 | Oral and Maxillofacial Surgery Outpatient Progress note | |
1005-8 | Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma | | |
10050-3 | S wave duration in lead II | |
100500-8 | Orthopaedic surgery Outpatient Progress note | |
100501-6 | Orthotics prosthetics Outpatient Progress note | |
100502-4 | Otolaryngology Outpatient Progress note | |
100503-2 | Pain medicine Outpatient Progress note | |
100504-0 | Palliative care Outpatient Progress note | |
100505-7 | Pediatric cardiology Outpatient Progress note | |
100506-5 | Pediatric dermatology Outpatient Progress note | |
100507-3 | Pediatric endocrinology Outpatient Progress note | |
100508-1 | Pediatric gastroenterology Outpatient Progress note | |
100509-9 | Pediatric hematology-oncology Outpatient Progress note | |
10051-1 | S wave duration in lead III | |
100510-7 | Pediatric infectious diseases Outpatient Progress note | |
100511-5 | Pediatric otolaryngology Outpatient Progress note | |
100512-3 | Pediatric pulmonology Outpatient Progress note | |
100513-1 | Pediatric rheumatology Outpatient Progress note | |
100514-9 | Pediatric surgery Outpatient Progress note | |
100515-6 | Pediatric transplant hepatology Outpatient Progress note | |
100516-4 | Pediatric urology Outpatient Progress note | |
100517-2 | Pharmacogenomics Outpatient Progress note | |
100518-0 | Physical medicine and rehab Outpatient Progress note | |
100519-8 | Physical therapy Outpatient Progress note | |
10052-9 | S wave duration in lead V1 | |
100520-6 | Plastic surgery Outpatient Progress note | |
100521-4 | Podiatry Outpatient Progress note | |
100522-2 | Psychiatry Hospital Progress note | |
100523-0 | Psychology Outpatient Progress note | |
100524-8 | Pulmonary Outpatient Progress note | |
100525-5 | Radiation oncology Outpatient Progress note | |
100526-3 | Radiology Outpatient Progress note | |
100527-1 | Recreational therapy Outpatient Progress note | |
100528-9 | Reproductive endocrinology and infertility Outpatient Progress note | |
100529-7 | Research Outpatient Progress note | |
10053-7 | S wave duration in lead V2 | |
100530-5 | Rheumatology Outpatient Progress note | |
100531-3 | Sleep medicine Outpatient Progress note | |
100532-1 | Social worker Outpatient Progress note | |
100533-9 | Solid Organ Transplant Outpatient Progress note | |
100534-7 | Speech-language pathology Outpatient Progress note | |
100535-4 | Spinal surgery Outpatient Progress note | |
100536-2 | Sports medicine Outpatient Progress note | |
100537-0 | Surgery of the hand Outpatient Progress note | |
100538-8 | Telehealth+Outpatient Progress note | |
100539-6 | Thromboembolism Outpatient Progress note | |
10054-5 | S wave duration in lead V3 | |
100540-4 | Transplant surgery Outpatient Progress note | |
100541-2 | Trauma Outpatient Progress note | |
100542-0 | Urology Outpatient Progress note | |
100543-8 | Vascular neurology Outpatient Progress note | |
100544-6 | Vascular surgery Outpatient Progress note | |
100545-3 | Wound care management Outpatient Progress note | |
100546-1 | Wound, Ostomy, and Continence Care Outpatient Progress note | |
100547-9 | Adolescent medicine Hospital Progress note | |
100548-7 | Allergy and Immunology Hospital Progress note | |
100549-5 | Allergy Hospital Progress note | |
10055-2 | S wave duration in lead V4 | |
100550-3 | Attending Hospital Progress note | |
100551-1 | Audiology Hospital Progress note | |
100552-9 | Bariatric surgery Hospital Progress note | |
100553-7 | Blood banking and transfusion medicine Hospital Progress note | |
100554-5 | Bone Marrow Transplant Hospital Progress note | |
100555-2 | Breastfeeding Hospital Progress note | |
100556-0 | Burn management Hospital Progress note | |
100557-8 | Cardiac surgery Hospital Progress note | |
100558-6 | Cardiopulmonary Hospital Progress note | |
100559-4 | Child and adolescent psychiatry Hospital Progress note | |
10056-0 | S wave duration in lead V5 | |
100560-2 | Clinical cardiac electrophysiology Hospital Progress note | |
100561-0 | Clinical genetics Hospital Progress note | |
100562-8 | Clinical neurophysiology Hospital Progress note | |
100563-6 | Clinical pathology Hospital Progress note | |
100564-4 | Colon and rectal surgery Hospital Progress note | |
100565-1 | Consultant Hospital Progress note | |
100566-9 | Dentistry Hospital Progress note | |
100567-7 | Dermatology Hospital Progress note | |
100568-5 | Developmental-behavioral pediatrics Hospital Progress note | |
100569-3 | Dialysis and Therapeutic apheresis Hospital Progress note | |
10057-8 | S wave duration in lead V6 | |
100570-1 | Eating disorders Hospital Progress note | |
100571-9 | Endocrinology Hospital Progress note | |
100572-7 | Family medicine Hospital Progress note | |
100573-5 | Gastroenterology Hospital Progress note | |
100574-3 | General medicine Hospital Progress note | |
100575-0 | Geriatric medicine Hospital Progress note | |
100576-8 | Gynecologic oncology Hospital Progress note | |
100577-6 | Gynecology Hospital Progress note | |
100578-4 | Healthcare navigator Hospital Progress note | |
100579-2 | Heart failure Hospital Progress note | |
10058-6 | S' wave amplitude in lead AVF | |
100580-0 | Heart failure+Transplant cardiology Hospital Progress note | |
100581-8 | Hematology Hospital Progress note | |
100582-6 | Hematology+Medical oncology Hospital Progress note | |
100583-4 | Hepatology Hospital Progress note | |
100584-2 | Immunology Hospital Progress note | |
100585-9 | Infectious disease Hospital Progress note | |
100586-7 | Internal medicine Hospital Progress note | |
100587-5 | Interventional cardiology Hospital Progress note | |
100588-3 | Interventional radiology Hospital Progress note | |
100589-1 | Hospital Mechanical circulatory support Progress note | |
10059-4 | S' wave amplitude in lead AVL | |
100590-9 | Medical Aid in Dying Hospital Progress note | |
100591-7 | Mental health Hospital Progress note | |
100592-5 | Multi-specialty program Hospital Progress note | |
100593-3 | Neonatal perinatal medicine Hospital Progress note | |
100594-1 | Nephrology Hospital Progress note | |
100595-8 | Neurological surgery Hospital Progress note | |
100596-6 | Neurology Hospital Progress note | |
100597-4 | Neurology with special qualifications in child neurology Hospital Progress note | |
100598-2 | Nurse practitioner Hospital Progress note | |
100599-0 | Nurse Hospital Progress note | |
1006-6 | Direct antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells | | |
10060-2 | S' wave amplitude in lead AVR | |
100600-6 | Nutrition and dietetics Hospital Progress note | |
100601-4 | Obstetrics and Gynecology Hospital Progress note | |
100602-2 | Obstetrics Hospital Progress note | |
100603-0 | Occupational therapy Hospital Progress note | |
100604-8 | Oncology Hospital Progress note | |
100605-5 | Ophthalmology Hospital Progress note | |
100606-3 | Oral and Maxillofacial Surgery Hospital Progress note | |
100607-1 | Orthopaedic surgery Hospital Progress note | |
100608-9 | Orthotics prosthetics Hospital Progress note | |
100609-7 | Otolaryngology Hospital Progress note | |
10061-0 | S' wave amplitude in lead I | |
100610-5 | Pain medicine Hospital Progress note | |
100611-3 | Palliative care Hospital Progress note | |
100612-1 | Pastoral care Hospital Progress note | |
100613-9 | Pediatric cardiology Hospital Progress note | |
100614-7 | Pediatric dermatology Hospital Progress note | |
100615-4 | Pediatric endocrinology Hospital Progress note | |
100616-2 | Pediatric gastroenterology Hospital Progress note | |
100617-0 | Pediatric hematology-oncology Hospital Progress note | |
100618-8 | Pediatric infectious diseases Hospital Progress note | |
100619-6 | Pediatric otolaryngology Hospital Progress note | |
10062-8 | S' wave amplitude in lead II | |
100620-4 | Pediatric pulmonology Hospital Progress note | |
100621-2 | Pediatric rheumatology Hospital Progress note | |
100622-0 | Pediatric surgery Hospital Progress note | |
100623-8 | Pediatric transplant hepatology Hospital Progress note | |
100624-6 | Pharmacogenomics Hospital Progress note | |
100625-3 | Pharmacology Hospital Progress note | |
100626-1 | Physical medicine and rehab Hospital Progress note | |
100627-9 | Physical therapy Hospital Progress note | |
100628-7 | Plastic surgery Hospital Progress note | |
100629-5 | Podiatry Hospital Progress note | |
10063-6 | S' wave amplitude in lead III | |
100630-3 | Psychology Hospital Progress note | |
100631-1 | Radiation oncology Hospital Progress note | |
100632-9 | Radiology Hospital Progress note | |
100633-7 | Rapid response team Hospital Progress note | |
100634-5 | Recreational therapy Hospital Progress note | |
100635-2 | Reproductive endocrinology and infertility Hospital Progress note | |
100636-0 | Research Hospital Progress note | |
100637-8 | Rheumatology Hospital Progress note | |
100638-6 | Sleep medicine Hospital Progress note | |
100639-4 | Social worker Hospital Progress note | |
10064-4 | S' wave amplitude in lead V1 | |
100640-2 | Solid Organ Transplant Hospital Progress note | |
100641-0 | Speech-language pathology Hospital Progress note | |
100642-8 | Spinal surgery Hospital Progress note | |
100643-6 | Surgery of the hand Hospital Progress note | |
100644-4 | Thromboembolism Hospital Progress note | |
100645-1 | Trauma Hospital Progress note | |
100646-9 | Urology Hospital Progress note | |
100647-7 | Vascular neurology Hospital Progress note | |
100648-5 | Vascular surgery Hospital Progress note | |
100649-3 | Wound care management Hospital Progress note | |
10065-1 | S' wave amplitude in lead V2 | |
100650-1 | Wound, Ostomy, and Continence Care Hospital Progress note | |
100651-9 | Hospital COVID-19 Intubation Progress note | |
100652-7 | Pure tone bone conduction threshold audiometry panel | |
100653-5 | Pure tone air conduction threshold audiometry panel | |
100654-3 | Pyruvate kinase M2 [Presence] in Stool | | |
100655-0 | XR Sella turcica Lateral | |
100656-8 | Maternal and fetal medicine Outpatient Progress note | |
100657-6 | Maternal and fetal medicine Telephone encounter+Hospital Progress note | |
100658-4 | Hospital COVID-19 Progress note | |
100659-2 | Maternal and fetal medicine Hospital Progress note | |
10066-9 | S' wave amplitude in lead V3 | |
100660-0 | Maternal and fetal medicine Telephone encounter+Outpatient Progress note | |
100661-8 | Psychiatry Outpatient Progress note | |
100662-6 | Cortisol free and total panel - Serum or Plasma | | |
100663-4 | TPMT gene c.460G>A and c.719A>G [Presence] in Blood by Molecular genetics method | | |
100664-2 | NUDT15 gene c.50_55dup and c.415C>T [Presence] in Blood by Molecular genetics method | | |
100665-9 | NUDT15 gene c.415C>T [Presence] in Blood by Molecular genetics method | | |
100666-7 | NUDT15 gene c.416G>A [Presence] in Blood by Molecular genetics method | | |
100667-5 | NUDT15 gene c.52G>A [Presence] in Blood by Molecular genetics method | | |
100668-3 | NUDT15 gene c.50_55dup [Presence] in Blood by Molecular genetics method | | |
100669-1 | NUDT15 gene c.50_55del [Presence] in Blood by Molecular genetics method | | |
10067-7 | S' wave amplitude in lead V4 | |
100670-9 | RHD gene allele [Identifier] in Plasma cell-free DNA Nominal--fetus | | |
100671-7 | Aspergillus sp DNA [Presence] in Blood by NAA with probe detection | | |
100672-5 | Aspergillus fumigatus DNA [Presence] in Blood by NAA with probe detection | | |
100673-3 | Aspergillus terreus DNA [Presence] in Blood by NAA with probe detection | | |
100674-1 | BK virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | | |
100675-8 | Cytomegalovirus DNA [Units/volume] (viral load) in Blood by NAA with probe detection | | |
100676-6 | Cytomegalovirus DNA [log units/volume] (viral load) in Blood by NAA with probe detection | | |
100677-4 | Epstein Barr virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | | |
100678-2 | Epstein Barr virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | | |
100679-0 | Herpes virus 6 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | | |
10068-5 | S' wave amplitude in lead V5 | |
100680-8 | Herpes virus 6 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | | |
100681-6 | Herpes virus 7 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | | |
100682-4 | Herpes virus 7 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | | |
100683-2 | Herpes virus 8 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | | |
100684-0 | Herpes virus 8 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | | |
100685-7 | JC virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | | |
100686-5 | JC virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | | |
100687-3 | JC virus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection | | |
100688-1 | Parvovirus B19 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | | |
100689-9 | Toxoplasma gondii DNA [Log #/volume] in Serum or Plasma by NAA with probe detection | | |
10069-3 | S' wave amplitude in lead V6 | |
100690-7 | Toxoplasma gondii DNA [Log #/volume] in Cerebral spinal fluid by NAA with probe detection | | |
100691-5 | Varicella zoster virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | | |
100692-3 | Varicella zoster virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | | |
100693-1 | Pneumocystis jiroveci DNA [Log #/volume] in Respiratory specimen by NAA with probe detection | | |
100694-9 | SMN1 gene silent carrier analysis [Presence] in Blood or Tissue by Molecular genetics method | | |
100695-6 | Genetic disease analysis overall carrier interpretation in Blood or Tissue by Molecular genetics method Narrative | | |
100696-4 | CTNS related multigene analysis [Identifier] in Bodyfluid and Serum or Plasma by Molecular genetics method Nominal | | |
100697-2 | Interventional radiology Outpatient Note | |
100698-0 | Social Determinants of Health screening report Document | |
100699-8 | Rifabutin+Ethambutol [Susceptibility] | | |
1007-4 | Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells | | |
10070-1 | S' wave duration in lead AVF | |
100700-4 | Trichomonas vaginalis DNA [Presence] in Urethra by NAA with probe detection | | |
100701-2 | Trichomonas vaginalis rRNA [Presence] in Urethra by NAA with probe detection | | |
100702-0 | Mycoplasma genitalium rRNA [Presence] in Urethra by NAA with probe detection | | |
100703-8 | Mycoplasma genitalium rRNA [Presence] in Urine by NAA with probe detection | | |
100704-6 | Mycoplasma genitalium rRNA [Presence] in Cervix by NAA with probe detection | | |
100705-3 | Mycoplasma genitalium rRNA [Presence] in Anorectal by NAA with probe detection | | |
100706-1 | Mycoplasma genitalium rRNA [Presence] in Specimen by NAA with probe detection | | |
100707-9 | Polymorphonuclear cells [#/volume] in Peritoneal dialysis fluid by Automated count | | |
100708-7 | Plasma cells/100 leukocytes in Synovial fluid | | |
100709-5 | Hepatocellular carcinoma risk [Score] by GAAD | | |
10071-9 | S' wave duration in lead AVL | |
100710-3 | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Throat by NAA with probe detection | | |
100711-1 | Borrelia burgdorferi.VlsE1+pepC10 Ab [Units/volume] in Serum by Immunoassay | | |
100712-9 | Brexpiprazole [Mass/volume] in Serum or Plasma | | |
100713-7 | Cariprazine [Mass/volume] in Serum or Plasma | | |
100714-5 | Guanfacine [Mass/volume] in Serum or Plasma | | |
100715-2 | Prothipendyl [Mass/volume] in Serum or Plasma | | |
100716-0 | Prostate specific Ag [Mass/volume] in DBS | | |
100717-8 | FCGR3A gene.p.Phe176Val [Presence] in Blood or Tissue by Molecular genetics method | | |
100718-6 | Undersea and hyperbaric medicine Discharge summary | |
100719-4 | Surgical oncology Discharge summary | |
10072-7 | S' wave duration in lead AVR | |
100720-2 | Reproductive endocrinology and infertility Discharge summary | |
100721-0 | Community health care Discharge summary | |
100722-8 | Integrative medicine Discharge summary | |
100723-6 | Sports medicine Discharge summary | |
100724-4 | Diabetology Discharge summary | |
100725-1 | Optometry Discharge summary | |
100726-9 | Podiatry Discharge summary | |
100727-7 | Chiropractic medicine Discharge summary | |
100728-5 | Cardiac surgery Discharge summary | |
100729-3 | Breastfeeding Discharge summary | |
10073-5 | S' wave duration in lead I | |
100730-1 | Transplant surgery Discharge summary | |
100731-9 | Urgent care center Discharge summary | |
100732-7 | Cholesterol.in lipoprotein (little a) and Cholesterol.in LDL panel - Serum | | |
100733-5 | Cholesterol in LDL [Mass/volume] in Serum by calculation --corrected for Cholesterol.in lipoprotein (little a) | | |
100734-3 | traMADol and Metabolites Panel - Urine by Confirmatory method | | |
100735-0 | Mannose-6-phosphate isomerase and phosphomannomutase 1 panel - Leukocytes | | |
100736-8 | Acylcarnitine Analysis Post Mortem in Specimen Document | | |
100737-6 | Alkaline phosphatase.macromolecular [Presence] in Serum or Plasma | | |
100738-4 | Alanine aminotransferase.macromolecular [Presence] in Serum or Plasma | | |
100739-2 | Aspartate aminotransferase.macromolecular [Presence] in Serum or Plasma | | |
10074-3 | S' wave duration in lead II | |
100740-0 | Amylase.macromolecular [Presence] in Serum or Plasma | | |
100741-8 | Gamma glutamyl transferase.macromolecular [Presence] in Serum or Plasma | | |
100742-6 | Lactate dehydrogenase.macromolecular [Presence] in Serum or Plasma | | |
100743-4 | Lipase.macromolecular [Presence] in Serum or Plasma | | |
100744-2 | Alpha-1-acid glycoprotein [Mass/volume] in Serum or Plasma by Electrophoresis | | |
100745-9 | Chloride [Moles/volume] in Mixed venous blood | | |
100746-7 | Glucose [Moles/volume] in Mixed venous blood | | |
100747-5 | Legionella serogroup panel - Specimen | | |
100748-3 | Legionella spp [Presence] in Specimen by NAA with probe detection | | |
100749-1 | Legionella pneumophila serogroup 1 [Presence] in Specimen by NAA with probe detection | | |
10075-0 | S' wave duration in lead III | |
100750-9 | Legionella pneumophila non-serogroup 1 [Presence] in Specimen by NAA with probe detection | | |
100751-7 | Galactose-alpha-1,3-galactose (Alpha-Gal) panel - Serum or Plasma | | |
100752-5 | Exacerbating factors - Reported | |
100753-3 | Alleviating factors - Reported | |
100754-1 | Platelet disorders multigene analysis in Blood or Tissue by Sequencing | | |
100755-8 | Oligoclonal bands [#] in Serum or Plasma by Isoelectric focusing | | |
100756-6 | Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Isoelectric focusing | | |
100757-4 | Protein fractions.oligoclonal bands panel - Serum and CSF by Isoelectric focusing | | |
100758-2 | Estimated lung age by based on clinical data | |
100759-0 | Inspiratory reserve [Volume] Respiratory system by Spirometry | |
10076-8 | S' wave duration in lead V1 | |
100760-8 | XR Radius and Ulna - left Single view | |
100761-6 | PALB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | | |
100762-4 | HBA2 gene.c.377T>C [Presence] in Blood by Molecular genetics method | | |
100763-2 | Mycobacterium sp comparative reaction interpretation Narrative | | |
100764-0 | Mycobacterium bovis reaction wheal [Diameter] Qualitative --3 days post dose mammalian tuberculin intradermal | | |
100765-7 | Homocysteine and methylmalonate and methylcitrate panel - DBS | | |
100766-5 | Center for Epidemiologic Studies Depression Scale panel [CES-D] | | |
100767-3 | Bothered by things that are not usually bothersome | | |
100768-1 | Poor appetite | | |
100769-9 | Unhappy even with help from my family or friends | | |
10077-6 | S' wave duration in lead V2 | |
100770-7 | Feeling just as good as others | | |
100771-5 | Trouble focusing | | |
100772-3 | Feeling depressed | | |
100773-1 | Feeling everything is too much of an effort | | |
100774-9 | Feeling hopeful about the future | | |
100775-6 | Feeling life had been a failure | | |
100776-4 | Feeling fearful | | |
100777-2 | Restless sleep | | |
100778-0 | Feeling happy | | |
100779-8 | Quieter than usual | | |
10078-4 | S' wave duration in lead V3 | |
100780-6 | Feeling lonely | | |
100781-4 | People were unfriendly | | |
100782-2 | Enjoying life | | |
100783-0 | Crying spells | | |
100784-8 | Feeling sad | | |
100785-5 | Feeling people dislike me | | |
100786-3 | Lack of energy | | |
100787-1 | Total Score CES-D | | |
100788-9 | Stemphylium botryosum IgG4 Ab [Mass/volume] in Serum | | |
100789-7 | Rhizopus nigricans IgG4 Ab [Mass/volume] in Serum | | |
10079-2 | S' wave duration in lead V4 | |
100790-5 | Lepidoglyphus destructor IgG Ab [Mass/volume] in Serum | | |
100791-3 | Hamster epithelium IgG Ab [Mass/volume] in Serum | | |
100792-1 | Forsythia IgE Ab [Units/volume] in Serum | | |
100793-9 | Testosterone [Mass/volume] in Body fluid | | |
100794-7 | Follitropin [Units/volume] in Body fluid | | |
100795-4 | S100 calcium binding protein B [Mass/volume] in Body fluid | | |
100796-2 | Thyroglobulin [Mass/volume] in Body fluid | | |
100797-0 | Testosterone Free [Mass/volume] in Serum --1st specimen post XXX challenge | | |
100798-8 | Testosterone Free [Mass/volume] in Serum --2nd specimen post XXX challenge | | |
100799-6 | 21-Deoxycortisol [Mass/volume] in Serum --1st specimen post XXX challenge | | |
1008-2 | Indirect antiglobulin test.polyspecific reagent [Presence] in Serum or Plasma | | |
10080-0 | S' wave duration in lead V5 | |
100800-2 | 21-Deoxycortisol [Mass/volume] in Serum --2nd specimen post XXX challenge | | |
100801-0 | 21-Deoxycortisol [Mass/volume] in Serum --3rd specimen post XXX challenge | | |
100802-8 | 21-Deoxycortisol [Mass/volume] in Serum --4th specimen post XXX challenge | | |
100803-6 | 21-Deoxycortisol [Mass/volume] in Serum --5th specimen post XXX challenge | | |
100804-4 | Vasopressin [Moles/volume] in Plasma --1st specimen post XXX challenge | | |
100805-1 | Vasopressin [Moles/volume] in Plasma --2nd specimen post XXX challenge | | |
100806-9 | Vasopressin [Moles/volume] in Plasma --3rd specimen post XXX challenge | | |
100807-7 | Vasopressin [Moles/volume] in Plasma --4th specimen post XXX challenge | | |
100808-5 | Vasopressin [Moles/volume] in Plasma --5th specimen post XXX challenge | | |
100809-3 | Vasopressin [Moles/volume] in Plasma --6th specimen post XXX challenge | | |
10081-8 | S' wave duration in lead V6 | |
100810-1 | Vasopressin [Moles/volume] in Plasma --7th specimen post XXX challenge | | |
100811-9 | Vasopressin [Moles/volume] in Plasma --8th specimen post XXX challenge | | |
100812-7 | Vasopressin [Moles/volume] in Plasma --9th specimen post XXX challenge | | |
100813-5 | Vasopressin [Moles/volume] in Plasma --10th specimen post XXX challenge | | |
100814-3 | Vasopressin [Moles/volume] in Plasma --11th specimen post XXX challenge | | |
100815-0 | Vasopressin [Moles/volume] in Plasma --12th specimen post XXX challenge | | |
100816-8 | Glucagon [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge | | |
100817-6 | Glucagon [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge | | |
100818-4 | Renin [Mass/volume] in Plasma --1st specimen post XXX challenge | | |
100819-2 | Renin [Mass/volume] in Plasma --2nd specimen post XXX challenge | | |
10082-6 | ST initial amplitude 6 ms in lead AVF | |
100820-0 | Renin [Mass/volume] in Plasma --3rd specimen post XXX challenge | | |
100821-8 | National POLST form: portable medical order panel | |
100822-6 | Cardiopulmonary resuscitation orders | |
100823-4 | Initial portable medical treatment orders | |
100824-2 | Additional portable medical orders or instructions | |
100825-9 | Medically assisted nutrition orders | |
100826-7 | Portable medical order AndOr advance directive review | |
100827-5 | Portable medical order discussion participants | |
100828-3 | Portable medical order administrative information | |
100829-1 | Renin [Mass/volume] in Plasma --4th specimen post XXX challenge | | |
10083-4 | ST initial amplitude 6 ms in lead AVL | |
100830-9 | Alpha subunit free [Units/volume] in Serum or Plasma --1st specimen post XXX challenge | | |
100831-7 | Alpha subunit free [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge | | |
100832-5 | Alpha subunit free [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge | | |
100833-3 | Alpha subunit free [Units/volume] in Serum or Plasma --4th specimen post XXX challenge | | |
100834-1 | Alpha subunit free [Units/volume] in Serum or Plasma --5th specimen post XXX challenge | | |
100835-8 | Alpha subunit free [Units/volume] in Serum or Plasma --6th specimen post XXX challenge | | |
100836-6 | Alpha subunit free [Units/volume] in Serum or Plasma --7th specimen post XXX challenge | | |
100837-4 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | | |
100838-2 | Testosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | | |
100839-0 | Vitamin A/Retinol binding protein [Ratio] in Serum or Plasma | | |
10084-2 | ST initial amplitude 6 ms in lead AVR | |
100840-8 | IgE [Units/volume] in Body fluid | | |
100841-6 | Zinc finger protein of the cerebellum 4 Ab [Presence] in Cerebral spinal fluid by Line blot | | |
100842-4 | Nonalcoholic steatohepatitis score in Serum or Plasma Calculated by FAST | | |
100843-2 | Liver fibrosis score in Serum or Plasma by Calculated.Agile3+ | | |
100844-0 | Liver fibrosis score in Serum or Plasma by Calculated.Agile4 | | |
100845-7 | Neurofascin155 IgG4 Ab [Presence] in Serum by Flow cytometry (FC) | | |
100846-5 | Dengue virus 1+2+3+4 nsP1 IgG Ab [Presence] in Serum or Plasma by Immunoassay | | |
100847-3 | Gas and ammonia panel - Arterial blood | | |
100848-1 | Cell count and Differential panel - Amniotic fluid by Manual count | | |
100849-9 | Leukocytes [#/volume] in Amniotic fluid by Manual count | | |
10085-9 | ST initial amplitude 6 ms in lead I | |
100850-7 | Neutrophils [#/volume] in Amniotic fluid by Manual count | | |
100851-5 | Other cells [#/volume] in Amniotic fluid by Manual count | | |
100852-3 | NM Bones Views for metastasis W Sr-89 IV | |
100853-1 | NM Pericardial space Pericardial effusion | |
100854-9 | Lymphocytes/100 cells in Blood mononuclear cells by Immunoassay | | |
100855-6 | CD3 cells/100 cells in Blood mononuclear cells | | |
100856-4 | CD3+CD4+ (T4 helper) cells/100 cells in Blood mononuclear cells | | |
100857-2 | CD3+CD8+ (T8 suppressor) cells/100 cells in Blood mononuclear cells | | |
100858-0 | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | | |
100859-8 | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | | |
10086-7 | ST initial amplitude 6 ms in lead II | |
100860-6 | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | | |
100861-4 | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | | |
100862-2 | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | | |
100863-0 | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | | |
100864-8 | Giardia lamblia bg gene [Genotype] in Specimen by Molecular genetics method | | |
100865-5 | Avian schistosomes DNA [Presence] in Specimen by NAA with probe detection | | |
100866-3 | Febrile antibody profile in Serum | | |
100867-1 | Campylobacter jejuni+coli+lari+upsaliensis Ag [Presence] in Stool by Rapid immunoassay | | |
100868-9 | Cryptosporidium sp 18S-LC2 rRNA [Genotype] in Specimen by Molecular genetics method | | |
100869-7 | Cryptosporidium gp60 gene [Type] in Specimen by Molecular genetics method | | |
10087-5 | ST initial amplitude 6 ms in lead III | |
100870-5 | Cryptosporidium 18S rRNA [Genotype] in Specimen by Molecular genetics method | | |
100871-3 | Giardia lamblia gdh gene [Genotype] in Specimen by Molecular genetics method | | |
100872-1 | Bacteria producing polysaccharide from sucrose [Presence] in Isolate | | |
100873-9 | Giardia lamblia tpi gene [Genotype] in Specimen by Molecular genetics method | | |
100874-7 | Basidiobolus sp [Presence] in Specimen | | |
100875-4 | Fetal Heart Document limited US | |
100876-2 | Fetal Heart Document US | |
100877-0 | US Heart Transesophageal during surgery | |
100878-8 | Endoscopic ultrasound study Upper GI tract Document | |
100879-6 | US Guidance for cryoablation of Breast - right | |
10088-3 | ST initial amplitude 6 ms in lead V1 | |
100880-4 | US Guidance for cryoablation of Breast - left | |
100881-2 | MR Guidance for cryoablation of Bone | |
100882-0 | MR Peritoneum W contrast percutaneous intraperitoneal | |
100883-8 | MR Guidance for biopsy of Kidney - left | |
100884-6 | MR Guidance for biopsy of Kidney - right | |
100885-3 | Parapoxvirus DNA [Presence] in Specimen by NAA with probe detection | | |
100886-1 | Orf virus DNA [Presence] in Specimen by NAA with probe detection | | |
100887-9 | Pseudocowpox virus DNA [Presence] in Specimen by NAA with probe detection | | |
100888-7 | West African monkeypox virus DNA [Presence] in Specimen by NAA with probe detection | | |
100889-5 | Congo Basin monkeypox virus DNA [Presence] in Specimen by NAA with probe detection | | |
10089-1 | ST initial amplitude 6 ms in lead V2 | |
100890-3 | Poxvirus DNA panel | | |
100891-1 | Orthopoxvirus IgG Ab [Presence] in Serum or Plasma by Immunoassay | | |
100892-9 | Orthopoxvirus IgM Ab [Presence] in Serum or Plasma by Immunoassay | | |
100893-7 | Orthopoxvirus IgG and IgM Ab panel - Serum or Plasma | | |
100894-5 | Recommended screening frequency Narrative | |
100895-2 | Rickettsia conorii IgG and IgM [Interpretation] in Serum | | |
100896-0 | Vasopressin [Moles/volume] in Plasma --13th specimen post XXX challenge | | |
100897-8 | Staphylococcus aureus [Presence] in Specimen by Organism specific culture | | |
100898-6 | Lipid panel - Serum or Plasma | | |
100899-4 | Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype [Identifier] in Specimen by Organism specific culture | | |
10090-9 | | ST initial amplitude 6 ms in lead V3 | |
10091-7 | | ST initial amplitude 6 ms in lead V4 | |
10092-5 | | ST initial amplitude 6 ms in lead V5 | |
10093-3 | | ST initial amplitude 6 ms in lead V6 | |
10094-1 | | ST slope in lead AVF | |
10095-8 | | ST slope in lead AVL | |
10096-6 | | ST slope in lead AVR | |
100966-1 | | Oncofertility consultation note | |
100967-9 | | Fetal Document Fetal Heart Tracing | |
10097-4 | | ST slope in lead I | |
10098-2 | | ST slope in lead II | |
10099-0 | | ST slope in lead III | |
10100-6 | | ST slope in lead V1 | |
10101-4 | | ST slope in lead V2 | |
10102-2 | | ST slope in lead V3 | |
10103-0 | | ST slope in lead V4 | |
10104-8 | | ST slope in lead V5 | |
10105-5 | | ST slope in lead V6 | |
10106-3 | | ST wave end displacement in lead AVF | |
10107-1 | | ST wave end displacement in lead AVL | |
10108-9 | | ST wave end displacement in lead AVR | |
10109-7 | | ST wave end displacement in lead I | |
10110-5 | | ST wave end displacement in lead II | |
10111-3 | | ST wave end displacement in lead III | |
10112-1 | | ST wave end displacement in lead V1 | |
10113-9 | | ST wave end displacement in lead V2 | |
10114-7 | | ST wave end displacement in lead V3 | |
10115-4 | | ST wave end displacement in lead V4 | |
10116-2 | | ST wave end displacement in lead V5 | |
10117-0 | | ST wave end displacement in lead V6 | |
10118-8 | | ST wave mid displacement in lead AVF | |
10119-6 | | ST wave mid displacement in lead AVL | |
10120-4 | | ST wave mid displacement in lead AVR | |
10121-2 | | ST wave mid displacement in lead I | |
10122-0 | | ST wave mid displacement in lead II | |
10123-8 | | ST wave mid displacement in lead III | |
10124-6 | | ST wave mid displacement in lead V1 | |
10125-3 | | ST wave mid displacement in lead V2 | |
10126-1 | | ST wave mid displacement in lead V3 | |
10127-9 | | ST wave mid displacement in lead V4 | |
10128-7 | | ST wave mid displacement in lead V5 | |
10129-5 | | ST wave mid displacement in lead V6 | |
10130-3 | | T' wave amplitude in lead AVF | |
10131-1 | | T' wave amplitude in lead AVL | |
10132-9 | | T' wave amplitude in lead AVR | |
10133-7 | | T' wave amplitude in lead I | |
10134-5 | | T' wave amplitude in lead II | |
10135-2 | | T' wave amplitude in lead III | |
10136-0 | | T' wave amplitude in lead V1 | |
10137-8 | | T' wave amplitude in lead V2 | |
10138-6 | | T' wave amplitude in lead V3 | |
10139-4 | | T' wave amplitude in lead V4 | |
10140-2 | | T' wave amplitude in lead V5 | |
10141-0 | | T' wave amplitude in lead V6 | |
10142-8 | | T wave amplitude in lead AVF | |
10143-6 | | T wave amplitude in lead AVL | |
10144-4 | | T wave amplitude in lead AVR | |
10145-1 | | T wave amplitude in lead I | |
10146-9 | | T wave amplitude in lead II | |
10147-7 | | T wave amplitude in lead III | |
10148-5 | | T wave amplitude in lead V1 | |
10149-3 | | T wave amplitude in lead V2 | |
10150-1 | | T wave amplitude in lead V3 | |
10151-9 | | T wave amplitude in lead V4 | |
10152-7 | | T wave amplitude in lead V5 | |
10153-5 | | T wave amplitude in lead V6 | |
10154-3 | | Chief complaint Narrative - Reported | |
10155-0 | | History of allergies, reported | |
10156-8 | | History of Childhood diseases Narrative | |
10157-6 | | History of family member diseases Narrative | |
10158-4 | | History of Functional status Narrative | |
10159-2 | | History of Industrial exposure Narrative | |
10160-0 | | History of Medication use Narrative | |
10161-8 | | History of Occupational exposure Narrative | |
10162-6 | | History of pregnancies Narrative | |
10163-4 | | History of pregnancies | |
10164-2 | | History of Present illness Narrative | |
10165-9 | | Deprecated History of psychiatric symptoms and diseases Narrative | |
10166-7 | | History of Social function Narrative | |
10167-5 | | History of Surgical procedures Narrative | |
10168-3 | | History of Cardiovascular system disorders Narrative | |
10169-1 | | History of Ear disorders Narrative | |
10170-9 | | History of Endocrine system disorders Narrative | |
10171-7 | | History of Eyes disorders Narrative | |
10172-5 | | History of Hematologic system disorders Narrative | |
10173-3 | | History of Musculoskeletal system disorders Narrative | |
10174-1 | | History of Nose disorders Narrative | |
10175-8 | | History of Oral cavity disorders Narrative | |
10176-6 | | History of Reproductive system disorders Narrative | |
10177-4 | | History of Respiratory system disorders Narrative | |
10178-2 | | History of Skin disorders Narrative | |
10179-0 | | History of Throat and Neck disorders Narrative | |
10180-8 | | History of Throat and Neck disorders | |
10181-6 | | History of Urinary tract disorders Narrative | |
10182-4 | | History of Travel Narrative | |
10183-2 | | Hospital discharge medications Narrative | |
10184-0 | | Hospital discharge physical findings Narrative | |
10185-7 | | Hospital discharge procedures Narrative | |
10186-5 | | Identifying information Narrative Observed | |
10187-3 | | Review of systems Narrative - Reported | |
10188-1 | | Review of systems overview Narrative - Reported | |
10189-9 | | Review of systems overview - Reported | |
10190-7 | | Mental status Narrative | |
10191-5 | | Physical findings of Abdomen Narrative | |
10192-3 | | Physical findings of Back Narrative | |
10193-1 | | Physical findings of Breasts Narrative | |
10194-9 | | Physical findings of Neurologic deep tendon reflexes Narrative | |
10195-6 | | Physical findings of Ear Narrative | |
10196-4 | | Physical findings of Extremities Narrative | |
10197-2 | | Physical findings of Eye Narrative | |
10198-0 | | Physical findings of Genitourinary tract Narrative | |
10199-8 | | Physical findings of Head Narrative | |
10200-4 | | Physical findings of Heart Narrative | |
10201-2 | | Physical findings of Mouth and Throat and Teeth Narrative | |
10202-0 | | Physical findings of Nervous system Narrative | |
10203-8 | | Physical findings of Nose Narrative | |
10204-6 | | Physical findings of Pelvis Narrative | |
10205-3 | | Physical findings of Rectum Narrative | |
10206-1 | | Physical findings of Skin Narrative | |
10207-9 | | Physical findings of Thorax and Lungs Narrative | |
10208-7 | | Physical findings of Vessels Narrative | |
10209-5 | | Physical findings of Neurologic balance and Coordination Narrative | |
10210-3 | | Physical findings of General status Narrative | |
10211-1 | | Physical findings of Sense of touch Narrative | |
10212-9 | | Physical findings of Strength Narrative | |
10213-7 | | Surgical operation note anesthesia Narrative | |
10214-5 | | Surgical operation note anesthesia duration | |
10215-2 | | Surgical operation note findings Narrative | |
10216-0 | | Surgical operation note fluids Narrative | |
10217-8 | | Surgical operation note indications [Interpretation] Narrative | |
10218-6 | | Surgical operation note postoperative diagnosis Narrative | |
10219-4 | | Surgical operation note preoperative diagnosis Narrative | |
10220-2 | | Surgical operation note prep time duration | |
10221-0 | | Surgical operation note specimens taken Narrative | |
10222-8 | | Surgical operation note surgical complications [Interpretation] Narrative | |
10223-6 | | Surgical operation note surgical procedure Narrative | |
10224-4 | | Hemodynamic method special circumstances | |
10225-1 | | Cardiac measurement device Institution inventory number | |
10227-7 | | Cardiac measurement device Vendor model number | |
10228-5 | | Cardiac measurement device Vendor serial number | |
10229-3 | | Hemodynamic method Type of | |
10230-1 | | Left ventricular Ejection fraction | |
10231-9 | | Right ventricular Ejection fraction | |
10249-1 | | Heart rate device Institution inventory number | |
10250-9 | | Heart rate device Vendor model number | |
10251-7 | | Heart rate device Vendor serial number | |
10252-5 | | Biliary drain site | |
10253-3 | | Type of Biliary drain | |
10254-1 | | Type of Peritoneal drain | |
10255-8 | | Type of Subarachnoid drain | |
10256-6 | | Biliary drain Institution inventory number | |
10257-4 | | Chest tube Institution inventory number | |
10258-2 | | Enteral tube Institution inventory number | |
10259-0 | | Gastrostomy tube Institution inventory number | |
10260-8 | | GI tube Institution inventory number | |
10261-6 | | Intravascular tube Institution inventory number | |
10262-4 | | IO tube Institution inventory number | |
10263-2 | | Nasogastric tube Institution inventory number | |
10264-0 | | Oral tube Institution inventory number | |
10265-7 | | Peritoneal drain Institution inventory number | |
10266-5 | | Peritoneal tube Institution inventory number | |
10267-3 | | Rate control device Institution inventory number | |
10268-1 | | Stool collection device Institution inventory number | |
10269-9 | | Subarachnoid drain Institution inventory number | |
10270-7 | | Synovial drain Institution inventory number | |
10271-5 | | Tube or drain Institution inventory number | |
10272-3 | | Upper GI tube Institution inventory number | |
10273-1 | | Bladder irrigation tube Institution inventory number | |
10274-9 | | Urine tube Institution inventory number | |
10275-6 | | Wound drain device Institution inventory number | |
10276-4 | | Peritoneal drain site | |
10277-2 | | Stool collection site | |
10278-0 | | Subarachnoid drain site | |
10279-8 | | Biliary drain Vendor model number | |
10280-6 | | Chest tube Vendor model number | |
10281-4 | | Enteral tube Vendor model number | |
10282-2 | | Gastrostomy tube Vendor model number | |
10283-0 | | GI tube Vendor model number | |
10284-8 | | Intravascular tube Vendor model number | |
10285-5 | | IO tube Vendor model number | |
10286-3 | | Nasogastric tube Vendor model number | |
10287-1 | | Oral tube Vendor model number | |
10288-9 | | Peritoneal drain Vendor model number | |
10289-7 | | Peritoneal tube Vendor model number | |
10290-5 | | Rate control device Vendor model number | |
10291-3 | | Stool collection device Vendor model number | |
10292-1 | | Subarachnoid drain Vendor model number | |
10293-9 | | Synovial drain Vendor model number | |
10294-7 | | Tube or drain Vendor model number | |
10295-4 | | Upper GI tube Vendor model number | |
10296-2 | | Bladder irrigation tube Vendor model number | |
10297-0 | | Urine tube Vendor model number | |
10298-8 | | Wound drain device Vendor model number | |
10299-6 | | Biliary drain Vendor serial number | |
10300-2 | | Chest tube Vendor serial number | |
10301-0 | | Enteral tube Vendor serial number | |
10302-8 | | Gastrostomy tube Vendor serial number | |
10303-6 | | GI tube Vendor serial number | |
10304-4 | | Intravascular tube Vendor serial number | |
10305-1 | | IO tube Vendor serial number | |
10306-9 | | Nasogastric tube Vendor serial number | |
10307-7 | | Oral tube Vendor serial number | |
10308-5 | | Peritoneal drain Vendor serial number | |
10309-3 | | Peritoneal tube Vendor serial number | |
10310-1 | | Rate control device Vendor serial number | |
10311-9 | | Stool collection device Vendor serial number | |
10312-7 | | Subarachnoid drain Vendor serial number | |
10313-5 | | Synovial drain Vendor serial number | |
10314-3 | | Tube or drain Vendor serial number | |
10315-0 | | Upper GI tube Vendor serial number | |
10316-8 | | Bladder irrigation tube Vendor serial number | |
10317-6 | | Urine tube Vendor serial number | |
10318-4 | | Wound drain device Vendor serial number | |
10319-2 | | Enema device Institution inventory number | |
10320-0 | | Enema device Vendor model number | |
10321-8 | | Enema device Vendor serial number | |
10322-6 | | Potassium intake 24 hour | |
10323-4 | | Wound drain fluid [Appearance] Lower GI tract | |
10324-2 | | Breath rate device Institution inventory number | |
10325-9 | | Breath rate device Vendor model number | |
10326-7 | | Breath rate device Vendor serial number | |
10830-8 | | Deprecated Surgical operation note complications | |
10831-6 | | Surgical operation note complications [Interpretation] | |
11283-9 | | Acuity assessment [Function] at First encounter | |
11284-7 | | Acuity assessment practitioner identification | |
11285-4 | | Acuity assessment practitioner profession | |
11286-2 | | Alcohol binge episodes per month - Reported | |
11287-0 | | Alcoholic drinks per drinking day - Reported | |
11288-8 | | Arrival time documented | |
11289-6 | | Body temperature at First encounter | |
11290-4 | | Body temperature measurement site at First encounter | |
11291-2 | | Respiratory rate at First encounter | |
11292-0 | | Deprecated Chief complaint: Prid: Pt: ^Patient: Nom: Reported | |
11293-8 | | Type of Referral source | |
11294-6 | | Current employment Narrative - Reported | |
11295-3 | | Current employment - Reported | |
11296-1 | | ED clinical finding practitioner identifier | |
11297-9 | | ED clinical finding practitioner profession | |
11298-7 | | ED consultant practitioner identifier | |
11299-5 | | ED consultant practitioner profession | |
11300-1 | | ED diagnosis | |
11301-9 | | ED diagnosis type | |
11302-7 | | ED discharge disposition | |
11303-5 | | ED disposition consult/referral | |
11304-3 | | ED disposition diagnosis practitioner identification | |
11305-0 | | ED disposition diagnosis practitioner profession | |
11306-8 | | ED medication practitioner identification | |
11307-6 | | ED medication practitioner profession | |
11308-4 | | ED outcome observation practitioner identification | |
11309-2 | | ED outcome observation practitioner profession | |
11310-0 | | ED patient satisfaction report type | |
11311-8 | | ED procedure practitioner profession | |
11312-6 | | ED procedure practitioner identifier | |
11313-4 | | ED procedure result observation [Interpretation] | |
11314-2 | | ED procedure result type | |
11315-9 | | ED service level | |
11316-7 | | ED service level practitioner profession | |
11317-5 | | ED service level practitioner identification | |
11318-3 | | Ambulance transport agency EMS system | |
11319-1 | | Ambulance transport unit [Identifier] EMS system | |
11320-9 | | Feeding and dietary status Narrative - Reported | |
11321-7 | | Feeding and dietary status - Reported | |
11322-5 | | History of General health Narrative | |
11323-3 | | General health - Reported | |
11324-1 | | Glasgow coma score eye opening at First encounter | |
11325-8 | | Glasgow coma score motor at First encounter | |
11326-6 | | Glasgow coma score verbal at First encounter | |
11327-4 | | Heart rate method at First encounter | |
11328-2 | | Heart rate at First encounter | |
11329-0 | | History general Narrative - Reported | |
11330-8 | | History of Alcohol use Narrative | |
11331-6 | | History of Alcohol use | |
11332-4 | | History of Cognitive function Narrative | |
11333-2 | | History of Cognitive function | |
11334-0 | | History of Growth+Development Narrative | |
11335-7 | | History of Growth+Development | |
11336-5 | | History of Hospitalization Narrative | |
11337-3 | | History of Hospitalization | |
11338-1 | | History of Major illnesses and injuries Narrative | |
11339-9 | | History of Major illnesses and injuries | |
11340-7 | | History of Occupation Narrative | |
11341-5 | | History of Occupation | |
11342-3 | | History of Other nonmedical drug use Narrative | |
11343-1 | | History of Other nonmedical drug use | |
11344-9 | | History of Other social factors Narrative | |
11345-6 | | History of Other social factors | |
11346-4 | | History of Outpatient visits Narrative | |
11347-2 | | History of Outpatient visits | |
11348-0 | | History of Past illness Narrative | |
11349-8 | | History of Past illness | |
11350-6 | | History of Sexual behavior Narrative | |
11351-4 | | History of Sexual behavior | |
11352-2 | | History of Allergenic and Immunologic disorders Narrative | |
11353-0 | | History of Breasts disorders Narrative | |
11354-8 | | History of Ears and Nose and Sinuses and Mouth and Throat disorders Narrative | |
11355-5 | | History of Gastrointestinal system disorders Narrative | |
11356-3 | | History of Genitourinary systems disorders Narrative | |
11357-1 | | History of Integumentary system disorders Narrative | |
11358-9 | | History of Psychiatric disorders Narrative | |
11359-7 | | History of Allergenic and Immunologic disorders | |
11360-5 | | History of Breasts disorders | |
11361-3 | | History of Ears and Nose and Sinuses and Mouth and Throat disorders | |
11362-1 | | History of Gastrointestinal system disorders | |
11363-9 | | History of Genitourinary systems disorders | |
11364-7 | | History of Integumentary system disorders | |
11365-4 | | History of Psychiatric disorders | |
11366-2 | | History of Tobacco use Narrative | |
11367-0 | | History of Tobacco use | |
11368-8 | | Illness or injury onset date and time | |
11369-6 | | History of Immunization Narrative | |
11370-4 | | Immunization status - Reported | |
11371-2 | | Initial visit for chief complaint | |
11372-0 | | Injury associated activity | |
11373-8 | | Injury cause | |
11374-6 | | Injury incident description Narrative | |
11375-3 | | Injury intent | |
11376-1 | | Injury location | |
11377-9 | | Diastolic blood pressure at First encounter | |
11378-7 | | Systolic blood pressure at First encounter | |
11379-5 | | Deprecated Highest level of education [Time] - Reported | |
11380-3 | | Marital status and living arrangements Narrative - Reported | |
11381-1 | | Marital status and living arrangements - Reported | |
11382-9 | | Medication allergy - Reported | |
11383-7 | | Patient problem outcome Narrative | |
11384-5 | | Physical examination by organ systems | |
11385-2 | | Physical findings of Ankle Narrative | |
11386-0 | | Physical findings of Upper arm Narrative | |
11387-8 | | Physical findings of Axilla Narrative | |
11388-6 | | Physical findings of Buttocks Narrative | |
11389-4 | | Physical findings of Calf Narrative | |
11390-2 | | Physical findings of Cardiovascular system Narrative | |
11391-0 | | Physical findings of Chest Narrative | |
11392-8 | | Physical findings of Chest wall Narrative | |
11393-6 | | Physical findings of Ears and Nose and Mouth and Throat Narrative | |
11394-4 | | Physical findings of Elbow Narrative | |
11395-1 | | Deprecated Physical findings: Find: Pt: Extremities: Nar: Observed | |
11396-9 | | Deprecated Physical findings: Find: Pt: Extremities: Nar: Observed | |
11397-7 | | Physical findings of Foot Narrative | |
11398-5 | | Physical findings of Forearm Narrative | |
11399-3 | | Physical findings of Gastrointestinal system Narrative | |
11400-9 | | Physical findings of Genitalia Narrative | |
11401-7 | | Physical findings of Female genitalia Narrative | |
11402-5 | | Physical findings of Male genitalia Narrative | |
11403-3 | | Physical findings of Groin Narrative | |
11404-1 | | Physical findings of Hand Narrative | |
11405-8 | | Deprecated Physical findings: Find: Pt: Heart: Nar: Observed | |
11406-6 | | Physical findings of Hip Narrative | |
11407-4 | | Physical findings of Knee Narrative | |
11408-2 | | Deprecated Physical findings: Find: Pt: Mouth & Throat & Teeth: Nar: Observed | |
11409-0 | | Deprecated Physical findings: Find: Pt: Mouth & Throat & Teeth: Nar: Observed | |
11410-8 | | Physical findings of Musculoskeletal system Narrative | |
11411-6 | | Physical findings of Neck Narrative | |
11412-4 | | Physical findings of Respiratory system Narrative | |
11413-2 | | Physical findings of Shoulder Narrative | |
11414-0 | | Physical findings of Thigh Narrative | |
11415-7 | | Physical findings of Wrist Narrative | |
11416-5 | | Physical findings of Ankle | |
11417-3 | | Physical findings of Upper arm | |
11418-1 | | Physical findings of Axilla | |
11419-9 | | Physical findings of Buttocks | |
11420-7 | | Physical findings of Calf | |
11421-5 | | Physical findings of Cardiovascular system | |
11422-3 | | Physical findings of Chest | |
11423-1 | | Physical findings of Chest wall | |
11424-9 | | Physical findings of Ears and Nose and Mouth and Throat | |
11425-6 | | Physical findings of Elbow | |
11426-4 | | Deprecated Physical findings: Find: Pt: Extremities: Nom: Observed | |
11427-2 | | Deprecated Physical findings: Find: Pt: Extremities: Nom: Observed | |
11428-0 | | Physical findings of Foot | |
11429-8 | | Physical findings of Forearm | |
11430-6 | | Physical findings of Gastrointestinal system | |
11431-4 | | Physical findings of Genitalia | |
11432-2 | | Physical findings of Female genitalia | |
11433-0 | | Physical findings of Male genitalia | |
11434-8 | | Physical findings of Groin | |
11435-5 | | Physical findings of Hand | |
11436-3 | | Deprecated Physical findings: Find: Pt: Heart: Nom: Observed | |
11437-1 | | Physical findings of Hip | |
11438-9 | | Physical findings of Knee | |
11439-7 | | Deprecated Physical findings: Find: Pt: Mouth & Throat & Teeth: Nom: Observed | |
11440-5 | | Deprecated Physical findings: Find: Pt: Mouth & Throat & Teeth: Nom: Observed | |
11441-3 | | Physical findings of Musculoskeletal system | |
11442-1 | | Physical findings of Neck | |
11443-9 | | Physical findings of Respiratory system | |
11444-7 | | Physical findings of Shoulder | |
11445-4 | | Physical findings of Thigh | |
11446-2 | | Physical findings of Wrist | |
11447-0 | | Physical findings of Hematologic and Lymphatic and Immunologic System Narrative | |
11448-8 | | Physical findings of Hematologic and Lymphatic and Immunologic System | |
11449-6 | | Pregnancy status - Reported | |
11450-4 | | Problem list - Reported | |
11451-2 | | Psychiatric findings Narrative | |
11452-0 | | Psychiatric findings | |
11453-8 | | Receiving facility EMS system | |
11454-6 | | Responsiveness assessment at First encounter | |
11455-3 | | Deprecated Review of symptoms and diseases: Find: Pt: ^Patient: Nar: Reported | |
11456-1 | | Deprecated Review of symptoms and diseases: Find: Pt: ^Patient: Nom: Reported | |
11457-9 | | Safety equipment used | |
11458-7 | | Clostridium tetani immunization status | |
11459-5 | | Transport mode EMS system | |
11485-0 | | Anesthesia records | |
11486-8 | | Chemotherapy records | |
11488-4 | | Consult note | |
11490-0 | | Physician Discharge summary | |
11491-6 | | Deprecated Provider-unspecified ED visit note | |
11492-6 | | Provider-unspecifed, History and physical note | |
11493-4 | | Hospital discharge studies summary Narrative | |
11494-2 | | Deprecated Physician Initial assessment note at First encounter | |
11495-9 | | Deprecated Physical therapy Initial assessment note at First encounter | |
11496-7 | | Deprecated Podiatry Initial assessment note at First encounter | |
11497-5 | | Deprecated Psychology Initial assessment note at First encounter | |
11498-3 | | Deprecated Social work Initial assessment note at First encounter | |
11499-1 | | Deprecated Speech therapy Initial assessment note at First encounter | |
11500-6 | | Deprecated Occupational therapy Initial assessment note at First encounter | |
11501-6 | | Deprecated Labor and delivery records | |
11502-2 | | Laboratory report | |
11503-0 | | Medical records | |
11504-8 | | Surgical operation note | |
11505-5 | | Physician procedure note | |
11506-3 | | Progress note | |
11507-1 | | Occupational therapy Progress note | |
11508-9 | | Physical therapy Progress note | |
11509-7 | | Podiatry Progress note | |
11510-5 | | Psychology Progress note | |
11511-3 | | Deprecated Provider-unspecified progress note | |
11512-1 | | Speech-language pathology Progress note | |
11513-9 | | Provider.signing [Identifier] Report | |
11514-7 | | Chiropractic Episode of care medical records | |
11515-4 | | Physical therapy Episode of care medical records | |
11516-2 | | Physician Episode of care medical records | |
11517-0 | | Podiatry Episode of care medical records | |
11518-8 | | Psychology Episode of care medical records | |
11519-6 | | Social service Episode of care medical records | |
11520-4 | | Speech therapy Episode of care medical records | |
11521-2 | | Occupational therapy Episode of care medical records | |
11523-8 | | EEG study | |
11524-6 | | EKG study | |
11525-3 | | US for pregnancy | |
11527-9 | | Psychiatry study | |
11530-3 | | Surgeon.assisting [Identifier] | |
11531-1 | | Surgeon.resident [Identifier] | |
11532-9 | | Surgeon.staff [Identifier] | |
11533-7 | | Surgical drains | |
11534-5 | | Temperature charts | |
11535-2 | | Hospital discharge Dx Narrative | |
11537-8 | | Surgical drains Narrative | |
11543-6 | | Nursery records | |
11544-4 | | Hospital discharge follow-up Narrative | |
11612-9 | | [#] Abortions | |
11613-7 | | [#] Abortions.induced | |
11614-5 | | [#] Abortions.spontaneous | |
11615-2 | | Fetal Heart Activity US | |
11616-0 | | Fetal Heart Narrative Activity US | |
11617-8 | | Fetal Limbs Activity US | |
11618-6 | | Fetal Limbs Narrative Activity US | |
11619-4 | | Fetal Respiratory Activity US | |
11620-2 | | Fetal Respiratory Narrative Activity US | |
11621-0 | | Fetal Trunk Activity US | |
11622-8 | | Fetal Trunk Narrative Activity US | |
11623-6 | | Fetal Quadrant four Amniotic fluid index derived by US | |
11624-4 | | Fetal Quadrant four one Amniotic fluid index derived by US | |
11625-1 | | Fetal Quadrant three Amniotic fluid index derived by US | |
11626-9 | | Fetal Quadrant two Amniotic fluid index derived by US | |
11627-7 | | Fetal Amniotic fluid index.sum derived by US | |
11628-5 | | Fetal Head Binocular distance estimated from Biparietal diameter on US | |
11629-3 | | Fetal Head Binocular distance US | |
11630-1 | | Fetal Biophysical profile.amniotic fluid volume US | |
11631-9 | | Fetal Biophysical profile.body movement US | |
11632-7 | | Fetal Biophysical profile.breathing movement US | |
11633-5 | | Fetal Heart rate reactivity US | |
11634-3 | | Fetal Biophysical profile.sum Derived | |
11635-0 | | Fetal Biophysical profile.tone US | |
11636-8 | | [#] Births.live | |
11637-6 | | [#] Births.preterm | |
11638-4 | | [#] Births.still living | |
11639-2 | | [#] Births.term | |
11640-0 | | [#] Births total | |
11641-8 | | Fetal Mitral valve Peak A wave US.doppler | |
11642-6 | | Deprecated Mitral valve Blood flow.diastolic.atrial wave.max by US.doppler | |
11643-4 | | Fetal Tricuspid valve Peak A wave US.doppler | |
11644-2 | | Deprecated Tricuspid valve Peak A velocity US.doppler | |
11645-9 | | Fetal Mitral valve Peak E wave US.doppler | |
11646-7 | | Deprecated Mitral valve Peak E velocity US.doppler | |
11647-5 | | Fetal Tricuspid valve Peak E wave US.doppler | |
11648-3 | | Deprecated Tricuspid valve Peak E velocity US.doppler | |
11649-1 | | Fetal Mitral valve E-wave/A-wave US.doppler | |
11650-9 | | Deprecated Mitral valve Blood flow.diastolic.early wave/Atrial wave Doppler.measured | |
11651-7 | | Fetal Tricuspid valve E-wave/A-wave US.doppler | |
11652-5 | | Deprecated Tricuspid valve Blood flow.diastolic.early wave/Atrial wave Doppler.measured | |
11653-3 | | Circulatory system End diastolic blood flow velocity US.doppler | |
11654-1 | | Fetal Cerebral artery anterior Minimal flow velocity US.doppler | |
11655-8 | | Cerebral artery anterior Minimal flow velocity US.doppler | |
11656-6 | | Fetal Cerebral artery middle Minimal flow velocity US.doppler | |
11657-4 | | Cerebral artery middle Minimal flow velocity US.doppler | |
11658-2 | | Ovarian artery - left Minimal flow velocity US.doppler | |
11659-0 | | Ovarian artery - right Minimal flow velocity US.doppler | |
11660-8 | | Fetal Umbilical artery at fetus Minimal flow velocity US.doppler | |
11661-6 | | Fetal Umbilical artery at placenta Minimal flow velocity US.doppler | |
11662-4 | | Fetal Umbilical artery between fetus and placenta Minimal flow velocity US.doppler | |
11663-2 | | Uterine artery - left Minimal flow velocity US.doppler | |
11664-0 | | Uterine artery - right Minimal flow velocity US.doppler | |
11665-7 | | Circulatory system Minimal flow velocity US.doppler | |
11666-5 | | Fetal Aorta ascending Mean blood flow velocity US.doppler | |
11667-3 | | Aorta ascending Mean blood flow velocity US.doppler | |
11668-1 | | Fetal Aorta descending Mean blood flow velocity US.doppler | |
11669-9 | | Aorta descending Mean blood flow velocity US.doppler | |
11670-7 | | Fetal Aortic arch Mean blood flow velocity US.doppler | |
11671-5 | | Aortic arch Mean blood flow velocity US.doppler | |
11672-3 | | Fetal Cerebral artery anterior Mean blood flow velocity US.doppler | |
11673-1 | | Cerebral artery anterior Mean blood flow velocity US.doppler | |
11674-9 | | Cerebral artery middle Mean blood flow velocity US.doppler | |
11675-6 | | Fetal Ductus arteriosus Mean blood flow velocity US.doppler | |
11676-4 | | Ductus arteriosus Mean blood flow velocity US.doppler | |
11677-2 | | Fetal Pulmonic valve Mean blood flow velocity US.doppler | |
11678-0 | | Pulmonic valve Mean blood flow velocity by US.doppler | |
11679-8 | | Fetal Left ventricular outflow tract Mean blood flow velocity US.doppler | |
11680-6 | | Deprecated Left ventricular outflow tract Mean blood flow Doppler.measured | |
11681-4 | | Fetal Right ventricular outflow tract Mean blood flow velocity US.doppler | |
11682-2 | | Deprecated Right ventricular outflow tract Mean blood flow Doppler.measured | |
11683-0 | | Ovarian artery - left Mean blood flow velocity US.doppler | |
11684-8 | | Ovarian artery - right Mean blood flow velocity US.doppler | |
11685-5 | | Fetal Main pulmonary artery Mean blood flow velocity US.doppler | |
11686-3 | | Main pulmonary artery Mean blood flow velocity US.doppler | |
11687-1 | | Fetal Umbilical artery at fetus Mean blood flow velocity US.doppler | |
11688-9 | | Fetal Umbilical artery at placenta Mean blood flow US.doppler | |
11689-7 | | Fetal Umbilical artery between fetus and placenta Mean blood flow US.doppler | |
11690-5 | | Uterine artery - left Mean blood flow US.doppler | |
11691-3 | | Uterine artery - right Mean blood flow US.doppler | |
11692-1 | | Circulatory system Maximum blood flow velocity mean US.doppler | |
11693-9 | | Fetal Aorta ascending Peak systolic flow velocity US.doppler | |
11694-7 | | Aorta ascending Peak systolic flow velocity US.doppler | |
11695-4 | | Fetal Aorta descending Peak systolic flow velocity US.doppler | |
11696-2 | | Aorta descending Peak systolic flow velocity US.doppler | |
11697-0 | | Fetal Aortic arch Peak systolic flow velocity US.doppler | |
11698-8 | | Aortic arch Peak systolic flow velocity US.doppler | |
11699-6 | | Fetal Cerebral artery anterior Peak systolic flow velocity US.doppler | |
11700-2 | | Cerebral artery anterior Peak systolic flow velocity US.doppler | |
11701-0 | | Fetal Cerebral artery middle Peak systolic flow velocity US.doppler | |
11702-8 | | Cerebral artery middle Peak systolic flow velocity US.doppler | |
11703-6 | | Fetal Ductus arteriosus Peak systolic flow velocity US.doppler | |
11704-4 | | Ductus arteriosus Peak systolic flow velocity US.doppler | |
11705-1 | | Fetal Aortic valve Peak systolic flow velocity US.doppler | |
11706-9 | | Aortic valve Peak systolic flow by US.doppler | |
11707-7 | | Fetal Mitral valve Peak systolic flow velocity US.doppler | |
11708-5 | | Mitral valve Peak systolic flow velocity by US.doppler | |
11709-3 | | Fetal Pulmonic valve Peak systolic flow velocity US.doppler | |
11710-1 | | Pulmonic valve Peak systolic flow velocity by US.doppler | |
11711-9 | | Fetal Tricuspid valve Peak systolic flow velocity US.doppler | |
11712-7 | | Tricuspid valve Peak systolic flow velocity by US.doppler | |
11713-5 | | Fetal Left ventricular outflow tract Peak systolic flow velocity US.doppler | |
11714-3 | | Deprecated Left ventricular outflow tract Peak systolic flow Doppler.measured | |
11715-0 | | Fetal Right ventricular outflow tract Peak systolic flow velocity US.doppler | |
11716-8 | | Deprecated Right ventricular outflow tract Peak systolic flow Doppler.measured | |
11717-6 | | Ovarian artery - left Peak systolic flow velocity US.doppler | |
11718-4 | | Ovarian artery - right Peak systolic flow velocity US.doppler | |
11719-2 | | Fetal Main pulmonary artery Peak systolic flow velocity US.doppler | |
11720-0 | | Main pulmonary artery Peak systolic flow velocity US.doppler | |
11721-8 | | Fetal Umbilical artery at fetus Peak systolic flow velocity US.doppler | |
11722-6 | | Fetal Umbilical artery at placenta Peak systolic flow velocity US.doppler | |
11723-4 | | Fetal Umbilical artery between fetus and placenta Peak systolic flow velocity US.doppler | |
11724-2 | | Uterine artery - left Peak systolic flow velocity US.doppler | |
11725-9 | | Uterine artery - right Peak systolic flow velocity US.doppler | |
11726-7 | | Circulatory system Peak systolic flow velocity US.doppler | |
11727-5 | | Fetal Body weight estimated by US | |
11728-3 | | Fetal Body weight estimated from Abdominal circumference on US | |
11729-1 | | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter on US | |
11730-9 | | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length on US | |
11731-7 | | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length and Head circumference on US | |
11732-5 | | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length and Head circumference on US by Hadlock 1985 method | |
11733-3 | | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length and Head circumference on US by Roberts 1985 method | |
11734-1 | | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length on US by Hadlock 1984 method | |